| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | granulocyte colony-stimulating factor receptor binding | 3.64e-16 | 14 | 90 | 8 | GO:0005130 | |
| GeneOntologyMolecularFunction | GPI anchor binding | 3.95e-16 | 23 | 90 | 9 | GO:0034235 | |
| GeneOntologyMolecularFunction | filamin binding | 4.74e-15 | 29 | 90 | 9 | GO:0031005 | |
| GeneOntologyMolecularFunction | glycolipid binding | PSG1 PSG3 PSG4 PSG6 PSG9 CEACAM8 CEACAM6 PSG8 PLEKHA8 CEACAM1 | 1.47e-14 | 49 | 90 | 10 | GO:0051861 |
| GeneOntologyMolecularFunction | lipid transmembrane transporter activity | SLC22A8 PSG1 PSG3 PSG4 PSG6 PSG9 SLC27A1 CEACAM8 CEACAM6 PSG8 CEACAM1 | 2.35e-14 | 73 | 90 | 11 | GO:0170055 |
| GeneOntologyMolecularFunction | bile acid transmembrane transporter activity | 2.44e-14 | 34 | 90 | 9 | GO:0015125 | |
| GeneOntologyMolecularFunction | lipid transporter activity | SLC22A8 PSG1 PSG3 PSG4 PSG6 PSG9 SLC27A1 CEACAM8 TSPO CEACAM6 ATP11A PSG8 PLEKHA8 CEACAM1 | 2.27e-13 | 196 | 90 | 14 | GO:0005319 |
| GeneOntologyMolecularFunction | Toll-like receptor binding | 4.92e-13 | 29 | 90 | 8 | GO:0035325 | |
| GeneOntologyMolecularFunction | monocarboxylic acid transmembrane transporter activity | PSG1 PSG3 PSG4 PSG6 PSG9 SLC27A1 CEACAM8 CEACAM6 PSG8 CEACAM1 | 8.82e-12 | 90 | 90 | 10 | GO:0008028 |
| GeneOntologyMolecularFunction | organic hydroxy compound transmembrane transporter activity | 2.65e-11 | 70 | 90 | 9 | GO:1901618 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase binding | 1.36e-09 | 149 | 90 | 10 | GO:1990782 | |
| GeneOntologyMolecularFunction | protein phosphatase binding | CACNA1B PSG1 PSG3 PSG4 PSG6 PSG9 CEACAM8 CEACAM6 PSG8 STAT1 CEACAM1 | 2.70e-09 | 210 | 90 | 11 | GO:0019903 |
| GeneOntologyMolecularFunction | calmodulin binding | CACNA1A PSG1 PSG3 PSG4 PSG6 PSG9 CEACAM8 CEACAM6 PSG8 RYR1 CEACAM1 | 6.98e-09 | 230 | 90 | 11 | GO:0005516 |
| GeneOntologyMolecularFunction | phosphatase binding | CACNA1B PSG1 PSG3 PSG4 PSG6 PSG9 CEACAM8 CEACAM6 PSG8 STAT1 CEACAM1 | 2.90e-08 | 264 | 90 | 11 | GO:0019902 |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | PSG1 PSG3 PSG4 PSG6 PSG9 SLC27A1 CEACAM8 CEACAM6 PSG8 CEACAM1 | 3.21e-08 | 207 | 90 | 10 | GO:0046943 |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | PSG1 PSG3 PSG4 PSG6 PSG9 SLC27A1 CEACAM8 CEACAM6 PSG8 CEACAM1 | 3.36e-08 | 208 | 90 | 10 | GO:0005342 |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | SLC22A8 PSG1 PSG3 PSG4 PSG6 PSG9 SLC27A1 CEACAM8 CEACAM6 PSG8 CEACAM1 | 8.38e-08 | 293 | 90 | 11 | GO:0008514 |
| GeneOntologyMolecularFunction | growth factor receptor binding | 8.64e-08 | 173 | 90 | 9 | GO:0070851 | |
| GeneOntologyMolecularFunction | transporter activity | CACNA1A CACNA1B SLC22A8 SLC12A9 PSG1 PSG3 PSG4 PSG6 SV2A PSG9 SLC27A1 CEACAM8 SLC35E1 TSPO LRP2 CEACAM6 ATP11A PSG8 PLEKHA8 RYR1 CEACAM1 | 2.01e-07 | 1289 | 90 | 21 | GO:0005215 |
| GeneOntologyMolecularFunction | phosphatidylinositol binding | PSG1 PSG3 PSG4 PSG6 PSG9 CEACAM8 CEACAM6 PSG8 PLEKHA8 CEACAM1 | 1.60e-06 | 316 | 90 | 10 | GO:0035091 |
| GeneOntologyMolecularFunction | cytokine receptor binding | 2.00e-06 | 324 | 90 | 10 | GO:0005126 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | CACNA1A CACNA1B SLC22A8 SLC12A9 PSG1 PSG3 PSG4 PSG6 SV2A PSG9 SLC27A1 CEACAM8 SLC35E1 CEACAM6 PSG8 RYR1 CEACAM1 | 1.80e-05 | 1180 | 90 | 17 | GO:0022857 |
| GeneOntologyMolecularFunction | chondroitin hydrolase activity | 2.01e-05 | 2 | 90 | 2 | GO:0052757 | |
| GeneOntologyMolecularFunction | endogalactosaminidase activity | 2.01e-05 | 2 | 90 | 2 | GO:0033931 | |
| GeneOntologyMolecularFunction | lipid binding | CD1B PSG1 PSG3 PSG4 CYP4A11 PSG6 OPN3 PSG9 CEACAM8 TSPO CEACAM6 PSG8 SOAT2 PLEKHA8 CEACAM1 | 3.30e-05 | 988 | 90 | 15 | GO:0008289 |
| GeneOntologyMolecularFunction | actin binding | 5.91e-05 | 479 | 90 | 10 | GO:0003779 | |
| GeneOntologyMolecularFunction | protein homodimerization activity | NOG MYOM1 PSG1 PSG3 PSG4 PSG6 PSG9 CEACAM8 CEACAM6 PSG8 TLR9 STAT1 CEACAM1 | 7.13e-05 | 815 | 90 | 13 | GO:0042803 |
| GeneOntologyMolecularFunction | protein heterodimerization activity | 7.72e-05 | 398 | 90 | 9 | GO:0046982 | |
| GeneOntologyMolecularFunction | kinase binding | MYOM1 SLC22A8 PSG1 PSG3 PSG4 PSG6 SV2A PSG7 PSG9 CEACAM8 CEACAM6 PSG8 PDPK2P CEACAM1 | 1.06e-04 | 969 | 90 | 14 | GO:0019900 |
| GeneOntologyMolecularFunction | protein kinase binding | SLC22A8 PSG1 PSG3 PSG4 PSG6 SV2A PSG7 PSG9 CEACAM8 CEACAM6 PSG8 PDPK2P CEACAM1 | 1.42e-04 | 873 | 90 | 13 | GO:0019901 |
| GeneOntologyMolecularFunction | phospholipid binding | PSG1 PSG3 PSG4 PSG6 PSG9 CEACAM8 CEACAM6 PSG8 PLEKHA8 CEACAM1 | 1.78e-04 | 548 | 90 | 10 | GO:0005543 |
| GeneOntologyMolecularFunction | hexosyltransferase activity | 3.86e-04 | 211 | 90 | 6 | GO:0016758 | |
| GeneOntologyMolecularFunction | hyalurononglucosaminidase activity | 7.09e-04 | 9 | 90 | 2 | GO:0004415 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in regulation of cytosolic calcium levels | 7.09e-04 | 9 | 90 | 2 | GO:0099511 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels | 7.09e-04 | 9 | 90 | 2 | GO:0099626 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 1.17e-03 | 46 | 90 | 3 | GO:0005245 | |
| GeneOntologyMolecularFunction | hydrolase activity, hydrolyzing O-glycosyl compounds | 1.21e-03 | 103 | 90 | 4 | GO:0004553 | |
| GeneOntologyMolecularFunction | acetylglucosaminyltransferase activity | 1.24e-03 | 47 | 90 | 3 | GO:0008375 | |
| GeneOntologyMolecularFunction | high voltage-gated calcium channel activity | 1.76e-03 | 14 | 90 | 2 | GO:0008331 | |
| GeneOntologyMolecularFunction | glycosyltransferase activity | 1.93e-03 | 288 | 90 | 6 | GO:0016757 | |
| GeneOntologyMolecularFunction | amide binding | 2.33e-03 | 299 | 90 | 6 | GO:0033218 | |
| GeneOntologyMolecularFunction | hexosaminidase activity | 2.61e-03 | 17 | 90 | 2 | GO:0015929 | |
| GeneOntologyMolecularFunction | protein dimerization activity | NOG MYOM1 PSG1 PSG3 PSG4 PSG6 PSG9 CEACAM8 CEACAM6 PSG8 TLR9 STAT1 CEACAM1 | 2.84e-03 | 1205 | 90 | 13 | GO:0046983 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on glycosyl bonds | 4.10e-03 | 144 | 90 | 4 | GO:0016798 | |
| GeneOntologyMolecularFunction | UDP-glycosyltransferase activity | 5.08e-03 | 153 | 90 | 4 | GO:0008194 | |
| GeneOntologyMolecularFunction | collagen binding | 5.86e-03 | 81 | 90 | 3 | GO:0005518 | |
| GeneOntologyBiologicalProcess | negative regulation of brown fat cell proliferation | 5.43e-19 | 14 | 87 | 9 | GO:0070348 | |
| GeneOntologyBiologicalProcess | regulation of brown fat cell proliferation | 1.35e-18 | 15 | 87 | 9 | GO:0070347 | |
| GeneOntologyBiologicalProcess | positive regulation of homophilic cell adhesion | 1.35e-18 | 15 | 87 | 9 | GO:1903387 | |
| GeneOntologyBiologicalProcess | insulin receptor internalization | 3.08e-18 | 16 | 87 | 9 | GO:0038016 | |
| GeneOntologyBiologicalProcess | regulation of hepatocyte proliferation | PSG1 PSG3 PSG4 PSG6 PSG9 HPN WNT3A CEACAM8 CEACAM6 PSG8 CEACAM1 | 4.28e-18 | 38 | 87 | 11 | GO:2000345 |
| GeneOntologyBiologicalProcess | brown fat cell proliferation | 6.53e-18 | 17 | 87 | 9 | GO:0070342 | |
| GeneOntologyBiologicalProcess | insulin catabolic process | 6.53e-18 | 17 | 87 | 9 | GO:1901143 | |
| GeneOntologyBiologicalProcess | regulation of homophilic cell adhesion | 1.30e-17 | 18 | 87 | 9 | GO:1903385 | |
| GeneOntologyBiologicalProcess | negative regulation of hepatocyte proliferation | 4.46e-17 | 20 | 87 | 9 | GO:2000346 | |
| GeneOntologyBiologicalProcess | epithelial cell proliferation involved in liver morphogenesis | PSG1 PSG3 PSG4 PSG6 PSG9 HPN WNT3A CEACAM8 CEACAM6 PSG8 CEACAM1 | 4.62e-17 | 46 | 87 | 11 | GO:0072575 |
| GeneOntologyBiologicalProcess | hepatocyte proliferation | PSG1 PSG3 PSG4 PSG6 PSG9 HPN WNT3A CEACAM8 CEACAM6 PSG8 CEACAM1 | 4.62e-17 | 46 | 87 | 11 | GO:0072574 |
| GeneOntologyBiologicalProcess | negative regulation of fat cell proliferation | 7.79e-17 | 21 | 87 | 9 | GO:0070345 | |
| GeneOntologyBiologicalProcess | liver morphogenesis | PSG1 PSG3 PSG4 PSG6 PSG9 HPN WNT3A CEACAM8 CEACAM6 PSG8 CEACAM1 | 9.99e-17 | 49 | 87 | 11 | GO:0072576 |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immune response to tumor cell | 4.53e-16 | 15 | 87 | 8 | GO:0002856 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 4.53e-16 | 15 | 87 | 8 | GO:0002859 | |
| GeneOntologyBiologicalProcess | regulation of fat cell proliferation | 1.22e-15 | 27 | 87 | 9 | GO:0070344 | |
| GeneOntologyBiologicalProcess | granulocyte colony-stimulating factor signaling pathway | 1.70e-15 | 17 | 87 | 8 | GO:0038158 | |
| GeneOntologyBiologicalProcess | fat cell proliferation | 7.16e-15 | 32 | 87 | 9 | GO:0070341 | |
| GeneOntologyBiologicalProcess | negative regulation of feeding behavior | 9.81e-15 | 33 | 87 | 9 | GO:2000252 | |
| GeneOntologyBiologicalProcess | negative regulation of response to tumor cell | 1.40e-14 | 21 | 87 | 8 | GO:0002835 | |
| GeneOntologyBiologicalProcess | negative regulation of immune response to tumor cell | 1.40e-14 | 21 | 87 | 8 | GO:0002838 | |
| GeneOntologyBiologicalProcess | insulin metabolic process | 1.78e-14 | 35 | 87 | 9 | GO:1901142 | |
| GeneOntologyBiologicalProcess | negative regulation of granulocyte differentiation | 2.20e-14 | 22 | 87 | 8 | GO:0030853 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet aggregation | 3.36e-14 | 23 | 87 | 8 | GO:0090331 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 3.36e-14 | 23 | 87 | 8 | GO:0002858 | |
| GeneOntologyBiologicalProcess | positive regulation of vasculogenesis | 5.02e-14 | 24 | 87 | 8 | GO:2001214 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immune response to tumor cell | 5.02e-14 | 24 | 87 | 8 | GO:0002855 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated cytotoxicity directed against tumor cell target | 5.02e-14 | 24 | 87 | 8 | GO:0002420 | |
| GeneOntologyBiologicalProcess | negative regulation of fatty acid biosynthetic process | 5.28e-14 | 39 | 87 | 9 | GO:0045717 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity | 6.79e-14 | 40 | 87 | 9 | GO:0045953 | |
| GeneOntologyBiologicalProcess | common myeloid progenitor cell proliferation | 7.35e-14 | 25 | 87 | 8 | GO:0035726 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated immune response to tumor cell | 7.35e-14 | 25 | 87 | 8 | GO:0002423 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immunity | 8.67e-14 | 41 | 87 | 9 | GO:0002716 | |
| GeneOntologyBiologicalProcess | negative regulation of homotypic cell-cell adhesion | 2.09e-13 | 28 | 87 | 8 | GO:0034111 | |
| GeneOntologyBiologicalProcess | negative regulation of behavior | 2.16e-13 | 45 | 87 | 9 | GO:0048521 | |
| GeneOntologyBiologicalProcess | regulation of vasculogenesis | 2.88e-13 | 29 | 87 | 8 | GO:2001212 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte mediated cytotoxicity | 3.30e-13 | 47 | 87 | 9 | GO:0001911 | |
| GeneOntologyBiologicalProcess | bile acid and bile salt transport | 3.30e-13 | 47 | 87 | 9 | GO:0015721 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet activation | 5.25e-13 | 31 | 87 | 8 | GO:0010544 | |
| GeneOntologyBiologicalProcess | gland morphogenesis | NOG PSG1 PSG3 PSG4 PSG6 PSG9 HPN WNT3A CEACAM8 LAMA5 CEACAM6 PSG8 CEACAM1 | 5.56e-13 | 178 | 87 | 13 | GO:0022612 |
| GeneOntologyBiologicalProcess | negative regulation of bone resorption | 6.98e-13 | 32 | 87 | 8 | GO:0045779 | |
| GeneOntologyBiologicalProcess | regulation of blood vessel remodeling | 6.98e-13 | 32 | 87 | 8 | GO:0060312 | |
| GeneOntologyBiologicalProcess | negative regulation of cell killing | 8.77e-13 | 52 | 87 | 9 | GO:0031342 | |
| GeneOntologyBiologicalProcess | regulation of granulocyte differentiation | 9.18e-13 | 33 | 87 | 8 | GO:0030852 | |
| GeneOntologyBiologicalProcess | negative regulation of vascular permeability | 1.20e-12 | 34 | 87 | 8 | GO:0043116 | |
| GeneOntologyBiologicalProcess | negative regulation of bone remodeling | 1.20e-12 | 34 | 87 | 8 | GO:0046851 | |
| GeneOntologyBiologicalProcess | immune response to tumor cell | 1.78e-12 | 56 | 87 | 9 | GO:0002418 | |
| GeneOntologyBiologicalProcess | negative regulation of fatty acid metabolic process | 3.43e-12 | 60 | 87 | 9 | GO:0045922 | |
| GeneOntologyBiologicalProcess | regulation of feeding behavior | 4.01e-12 | 61 | 87 | 9 | GO:0060259 | |
| GeneOntologyBiologicalProcess | negative regulation of lipid biosynthetic process | PSG1 PSG3 PSG4 PSG6 PSG9 SLC27A1 CEACAM8 CEACAM6 PSG8 CEACAM1 | 5.09e-12 | 91 | 87 | 10 | GO:0051055 |
| GeneOntologyBiologicalProcess | monocarboxylic acid transport | PLA2R1 SLC22A8 PSG1 PSG3 PSG4 CYP4A11 PSG6 PSG9 SLC27A1 CEACAM8 CEACAM6 PSG8 CEACAM1 | 5.50e-12 | 213 | 87 | 13 | GO:0015718 |
| GeneOntologyBiologicalProcess | regulation of platelet aggregation | 7.57e-12 | 42 | 87 | 8 | GO:0090330 | |
| GeneOntologyBiologicalProcess | carboxylic acid transport | CACNA1A PLA2R1 SLC22A8 PSG1 PSG3 PSG4 CYP4A11 PSG6 SV2A PSG9 SLC27A1 CEACAM8 LRP2 CEACAM6 PSG8 CEACAM1 | 1.45e-11 | 410 | 87 | 16 | GO:0046942 |
| GeneOntologyBiologicalProcess | organic acid transport | CACNA1A PLA2R1 SLC22A8 PSG1 PSG3 PSG4 CYP4A11 PSG6 SV2A PSG9 SLC27A1 CEACAM8 LRP2 CEACAM6 PSG8 CEACAM1 | 1.56e-11 | 412 | 87 | 16 | GO:0015849 |
| GeneOntologyBiologicalProcess | response to tumor cell | 1.66e-11 | 71 | 87 | 9 | GO:0002347 | |
| GeneOntologyBiologicalProcess | negative regulation of tissue remodeling | 1.98e-11 | 47 | 87 | 8 | GO:0034104 | |
| GeneOntologyBiologicalProcess | regulation of fatty acid biosynthetic process | 2.15e-11 | 73 | 87 | 9 | GO:0042304 | |
| GeneOntologyBiologicalProcess | negative regulation of lipid metabolic process | PSG1 PSG3 PSG4 PSG6 PSG9 SLC27A1 CEACAM8 CEACAM6 PSG8 ALK CEACAM1 | 2.50e-11 | 145 | 87 | 11 | GO:0045833 |
| GeneOntologyBiologicalProcess | regulation of immune response to tumor cell | 2.82e-11 | 49 | 87 | 8 | GO:0002837 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity | 3.13e-11 | 76 | 87 | 9 | GO:0042269 | |
| GeneOntologyBiologicalProcess | lipid transport | PLA2R1 SLC22A8 PSG1 PSG3 PSG4 CYP4A11 PSG6 PSG9 SLC27A1 CEACAM8 TSPO CEACAM6 ATP11A PSG8 SOAT2 PLEKHA8 CEACAM1 | 3.28e-11 | 506 | 87 | 17 | GO:0006869 |
| GeneOntologyBiologicalProcess | regulation of response to tumor cell | 3.35e-11 | 50 | 87 | 8 | GO:0002834 | |
| GeneOntologyBiologicalProcess | regulation of epithelial cell proliferation | GPBAR1 NOG PSG1 PSG3 PSG4 PSG6 HYAL1 PSG9 HPN WNT3A CEACAM8 LAMA5 CEACAM6 POLD4 PSG8 STAT1 CEACAM1 | 4.19e-11 | 514 | 87 | 17 | GO:0050678 |
| GeneOntologyBiologicalProcess | organic anion transport | CACNA1A PLA2R1 SLC22A8 PSG1 PSG3 PSG4 CYP4A11 PSG6 SV2A PSG9 SLC27A1 CEACAM8 LRP2 CEACAM6 PSG8 PLEKHA8 CEACAM1 | 4.32e-11 | 515 | 87 | 17 | GO:0015711 |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immunity | 5.02e-11 | 80 | 87 | 9 | GO:0002715 | |
| GeneOntologyBiologicalProcess | regulation of homotypic cell-cell adhesion | 5.47e-11 | 53 | 87 | 8 | GO:0034110 | |
| GeneOntologyBiologicalProcess | negative regulation of lymphocyte mediated immunity | 7.05e-11 | 83 | 87 | 9 | GO:0002707 | |
| GeneOntologyBiologicalProcess | regulation of epidermal growth factor receptor signaling pathway | 9.76e-11 | 86 | 87 | 9 | GO:0042058 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte mediated cytotoxicity | 1.16e-10 | 124 | 87 | 10 | GO:0001910 | |
| GeneOntologyBiologicalProcess | negative regulation of osteoclast differentiation | 1.34e-10 | 59 | 87 | 8 | GO:0045671 | |
| GeneOntologyBiologicalProcess | granulocyte differentiation | 1.54e-10 | 60 | 87 | 8 | GO:0030851 | |
| GeneOntologyBiologicalProcess | lipid localization | PLA2R1 SLC22A8 PSG1 PSG3 PSG4 CYP4A11 PSG6 PSG9 SLC27A1 CEACAM8 TSPO CEACAM6 ATP11A PSG8 SOAT2 PLEKHA8 CEACAM1 | 1.82e-10 | 565 | 87 | 17 | GO:0010876 |
| GeneOntologyBiologicalProcess | regulation of ERBB signaling pathway | 1.99e-10 | 93 | 87 | 9 | GO:1901184 | |
| GeneOntologyBiologicalProcess | platelet aggregation | 2.42e-10 | 95 | 87 | 9 | GO:0070527 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte mediated immunity | 2.66e-10 | 96 | 87 | 9 | GO:0002704 | |
| GeneOntologyBiologicalProcess | regulation of platelet activation | 3.39e-10 | 66 | 87 | 8 | GO:0010543 | |
| GeneOntologyBiologicalProcess | regulation of endothelial cell differentiation | 3.84e-10 | 67 | 87 | 8 | GO:0045601 | |
| GeneOntologyBiologicalProcess | negative regulation of blood coagulation | 4.89e-10 | 69 | 87 | 8 | GO:0030195 | |
| GeneOntologyBiologicalProcess | epithelial cell proliferation | GPBAR1 NOG PSG1 PSG3 PSG4 PSG6 HYAL1 PSG9 HPN WNT3A CEACAM8 LAMA5 CEACAM6 POLD4 PSG8 STAT1 CEACAM1 | 4.93e-10 | 603 | 87 | 17 | GO:0050673 |
| GeneOntologyBiologicalProcess | energy homeostasis | 5.08e-10 | 144 | 87 | 10 | GO:0097009 | |
| GeneOntologyBiologicalProcess | regulation of bone resorption | 5.50e-10 | 70 | 87 | 8 | GO:0045124 | |
| GeneOntologyBiologicalProcess | negative regulation of hemostasis | 5.50e-10 | 70 | 87 | 8 | GO:1900047 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte mediated immunity | SHLD2 CD1B PSG1 PSG3 PSG4 PSG6 PSG9 CEACAM6 MICA PSG8 TLR9 PDPK2P CEACAM1 | 5.64e-10 | 309 | 87 | 13 | GO:0002703 |
| GeneOntologyBiologicalProcess | natural killer cell mediated cytotoxicity | 5.98e-10 | 105 | 87 | 9 | GO:0042267 | |
| GeneOntologyBiologicalProcess | regulation of vascular permeability | 6.18e-10 | 71 | 87 | 8 | GO:0043114 | |
| GeneOntologyBiologicalProcess | regulation of cell killing | 6.22e-10 | 147 | 87 | 10 | GO:0031341 | |
| GeneOntologyBiologicalProcess | negative regulation of coagulation | 6.93e-10 | 72 | 87 | 8 | GO:0050819 | |
| GeneOntologyBiologicalProcess | negative regulation of interleukin-1 production | 6.93e-10 | 72 | 87 | 8 | GO:0032692 | |
| GeneOntologyBiologicalProcess | negative regulation of small molecule metabolic process | 7.10e-10 | 149 | 87 | 10 | GO:0062014 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated immunity | 8.36e-10 | 109 | 87 | 9 | GO:0002228 | |
| GeneOntologyBiologicalProcess | liver development | PSG1 PSG3 PSG4 PSG6 PSG9 HPN WNT3A CEACAM8 CEACAM6 PSG8 CEACAM1 | 8.85e-10 | 202 | 87 | 11 | GO:0001889 |
| GeneOntologyBiologicalProcess | hepaticobiliary system development | PSG1 PSG3 PSG4 PSG6 PSG9 HPN WNT3A CEACAM8 CEACAM6 PSG8 CEACAM1 | 1.03e-09 | 205 | 87 | 11 | GO:0061008 |
| GeneOntologyBiologicalProcess | negative regulation of innate immune response | 1.25e-09 | 114 | 87 | 9 | GO:0045824 | |
| GeneOntologyBiologicalProcess | cellular response to insulin stimulus | PSG1 PSG3 PSG4 PSG6 PSG9 SLC27A1 CEACAM8 CEACAM6 PSG8 PDPK2P STAT1 CEACAM1 | 1.53e-09 | 271 | 87 | 12 | GO:0032869 |
| GeneOntologyBiologicalProcess | receptor-mediated endocytosis | MRC1 PLA2R1 PSG1 PSG3 PSG4 PSG6 PSG9 WNT3A CEACAM8 LRP2 CEACAM6 PSG8 CEACAM1 | 1.62e-09 | 337 | 87 | 13 | GO:0006898 |
| GeneOntologyBiologicalProcess | regulation of bone remodeling | 1.63e-09 | 80 | 87 | 8 | GO:0046850 | |
| GeneOntologyBiologicalProcess | vasculogenesis | 1.70e-09 | 118 | 87 | 9 | GO:0001570 | |
| GeneOntologyBiologicalProcess | homotypic cell-cell adhesion | 2.64e-09 | 124 | 87 | 9 | GO:0034109 | |
| GeneOntologyBiologicalProcess | negative regulation of myeloid leukocyte differentiation | 2.67e-09 | 85 | 87 | 8 | GO:0002762 | |
| GeneOntologyBiologicalProcess | regulation of sprouting angiogenesis | 2.67e-09 | 85 | 87 | 8 | GO:1903670 | |
| GeneOntologyCellularComponent | transforming growth factor beta ligand-receptor complex | 2.73e-18 | 16 | 87 | 9 | GO:0070021 | |
| GeneOntologyCellularComponent | lateral plasma membrane | 1.32e-10 | 90 | 87 | 9 | GO:0016328 | |
| GeneOntologyCellularComponent | cell surface | HYAL4 MRC1 PLA2R1 CD1B PSG1 PSG3 PSG4 PSG6 PSG7 MRC2 PSG9 HPN WNT3A CEACAM8 LRP2 CEACAM6 MICA PSG8 FCRL4 CTSB BTNL9 CEACAM1 | 6.16e-10 | 1111 | 87 | 22 | GO:0009986 |
| GeneOntologyCellularComponent | apical plasma membrane | SLC22A8 PSG1 PSG3 PSG4 CYP4A11 PSG6 PSG9 HPN CEACAM8 LRP2 CEACAM6 PSG8 TLR9 CTSB CEACAM1 | 1.48e-09 | 487 | 87 | 15 | GO:0016324 |
| GeneOntologyCellularComponent | ciliary membrane | 7.52e-09 | 98 | 87 | 8 | GO:0060170 | |
| GeneOntologyCellularComponent | serine/threonine protein kinase complex | 1.88e-08 | 157 | 87 | 9 | GO:1902554 | |
| GeneOntologyCellularComponent | adherens junction | 1.89e-08 | 212 | 87 | 10 | GO:0005912 | |
| GeneOntologyCellularComponent | apical part of cell | SLC22A8 PSG1 PSG3 PSG4 CYP4A11 PSG6 PSG9 HPN CEACAM8 LRP2 CEACAM6 PSG8 TLR9 CTSB CEACAM1 | 2.03e-08 | 592 | 87 | 15 | GO:0045177 |
| GeneOntologyCellularComponent | T cell receptor complex | 2.60e-08 | 163 | 87 | 9 | GO:0042101 | |
| GeneOntologyCellularComponent | basal plasma membrane | SLC22A8 PSG1 PSG3 PSG4 PSG6 PSG9 SLC27A1 CEACAM8 CEACAM6 PSG8 TLR9 CEACAM1 | 2.62e-08 | 354 | 87 | 12 | GO:0009925 |
| GeneOntologyCellularComponent | external side of plasma membrane | CD1B PSG1 PSG3 PSG4 PSG6 PSG9 LRP2 CEACAM6 MICA PSG8 FCRL4 CTSB BTNL9 CEACAM1 | 2.92e-08 | 519 | 87 | 14 | GO:0009897 |
| GeneOntologyCellularComponent | protein kinase complex | 3.75e-08 | 170 | 87 | 9 | GO:1902911 | |
| GeneOntologyCellularComponent | basal part of cell | SLC22A8 PSG1 PSG3 PSG4 PSG6 PSG9 SLC27A1 CEACAM8 CEACAM6 PSG8 TLR9 CEACAM1 | 5.38e-08 | 378 | 87 | 12 | GO:0045178 |
| GeneOntologyCellularComponent | basolateral plasma membrane | SLC22A8 PSG1 PSG3 PSG4 PSG6 PSG9 CEACAM8 CEACAM6 PSG8 TLR9 CEACAM1 | 9.07e-08 | 320 | 87 | 11 | GO:0016323 |
| GeneOntologyCellularComponent | side of membrane | CD1B PSG1 PSG3 PSG4 PSG6 PSG9 CEACAM8 LRP2 CEACAM6 MICA PSG8 FCRL4 CTSB BTNL9 RYR1 CNTN6 CEACAM1 | 1.00e-07 | 875 | 87 | 17 | GO:0098552 |
| GeneOntologyCellularComponent | receptor complex | GPBAR1 PLA2R1 PSG1 PSG3 PSG4 PSG6 PSG9 CEACAM8 LRP2 CEACAM6 PSG8 ALK CEACAM1 | 8.04e-07 | 581 | 87 | 13 | GO:0043235 |
| GeneOntologyCellularComponent | cell-cell junction | PSG1 PSG3 PSG4 PSG6 SV2A PSG9 HPN CEACAM8 LAMA3 CEACAM6 PSG8 KIRREL2 CEACAM1 | 9.73e-07 | 591 | 87 | 13 | GO:0005911 |
| GeneOntologyCellularComponent | transferase complex, transferring phosphorus-containing groups | 1.31e-06 | 335 | 87 | 10 | GO:0061695 | |
| GeneOntologyCellularComponent | anchoring junction | PSG1 PSG3 PSG4 PSG6 SV2A MRC2 PSG9 HPN PPFIA1 CEACAM8 LAMA3 CEACAM6 PSG8 PDPK2P KIRREL2 CEACAM1 | 2.36e-06 | 976 | 87 | 16 | GO:0070161 |
| GeneOntologyCellularComponent | plasma membrane signaling receptor complex | 1.52e-05 | 350 | 87 | 9 | GO:0098802 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | CACNA1A CACNA1B PSG1 PSG3 PSG4 PSG6 PSG9 WNT3A CEACAM8 CEACAM6 PSG8 RYR1 CEACAM1 | 2.10e-05 | 785 | 87 | 13 | GO:0098797 |
| GeneOntologyCellularComponent | cell projection membrane | 7.67e-05 | 431 | 87 | 9 | GO:0031253 | |
| GeneOntologyCellularComponent | laminin-5 complex | 1.02e-04 | 4 | 87 | 2 | GO:0005610 | |
| GeneOntologyCellularComponent | presynaptic active zone | 3.08e-04 | 141 | 87 | 5 | GO:0048786 | |
| GeneOntologyCellularComponent | laminin complex | 7.54e-04 | 10 | 87 | 2 | GO:0043256 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | PKMYT1 ZDHHC12 PIGP CYP4A11 HPN SLC27A1 SRD5A2 ATP11A TMEM214 TLR9 GBA2 SOAT2 RYR1 MYORG | 8.65e-04 | 1293 | 87 | 14 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | PKMYT1 ZDHHC12 PIGP CYP4A11 HPN SLC27A1 SRD5A2 ATP11A TMEM214 TLR9 GBA2 SOAT2 RYR1 MYORG | 9.05e-04 | 1299 | 87 | 14 | GO:0098827 |
| GeneOntologyCellularComponent | voltage-gated calcium channel complex | 9.29e-04 | 46 | 87 | 3 | GO:0005891 | |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | PKMYT1 ZDHHC12 PIGP CYP4A11 HPN SLC27A1 SRD5A2 ATP11A TMEM214 TLR9 GBA2 SOAT2 RYR1 MYORG | 1.11e-03 | 1327 | 87 | 14 | GO:0042175 |
| GeneOntologyCellularComponent | membrane protein complex | CACNA1A CACNA1B PIGP PSG1 PSG3 PSG4 PSG6 STXBP5L PSG9 WNT3A CEACAM8 CEACAM6 PSG8 RYR1 CEACAM1 | 1.23e-03 | 1498 | 87 | 15 | GO:0098796 |
| GeneOntologyCellularComponent | lysosome | HYAL4 CD1B HYAL1 CEACAM8 LRP2 CEACAM6 ATP11A TLR9 CTSB PGAP6 | 1.97e-03 | 811 | 87 | 10 | GO:0005764 |
| GeneOntologyCellularComponent | lytic vacuole | HYAL4 CD1B HYAL1 CEACAM8 LRP2 CEACAM6 ATP11A TLR9 CTSB PGAP6 | 1.97e-03 | 811 | 87 | 10 | GO:0000323 |
| GeneOntologyCellularComponent | Wnt signalosome | 1.98e-03 | 16 | 87 | 2 | GO:1990909 | |
| GeneOntologyCellularComponent | transferase complex | PIGP PSG1 PSG3 PSG4 PSG6 PSG9 CEACAM8 CEACAM6 POLD4 PSG8 CEACAM1 | 2.14e-03 | 963 | 87 | 11 | GO:1990234 |
| GeneOntologyCellularComponent | Golgi membrane | 3.07e-03 | 721 | 87 | 9 | GO:0000139 | |
| GeneOntologyCellularComponent | lysosomal membrane | 3.15e-03 | 462 | 87 | 7 | GO:0005765 | |
| GeneOntologyCellularComponent | lytic vacuole membrane | 3.15e-03 | 462 | 87 | 7 | GO:0098852 | |
| GeneOntologyCellularComponent | tertiary granule membrane | 3.51e-03 | 73 | 87 | 3 | GO:0070821 | |
| GeneOntologyCellularComponent | calcium channel complex | 3.51e-03 | 73 | 87 | 3 | GO:0034704 | |
| GeneOntologyCellularComponent | cilium | 4.09e-03 | 898 | 87 | 10 | GO:0005929 | |
| GeneOntologyCellularComponent | vacuole | HYAL4 CD1B HYAL1 CEACAM8 LRP2 CEACAM6 ATP11A TLR9 CTSB PGAP6 | 4.59e-03 | 913 | 87 | 10 | GO:0005773 |
| GeneOntologyCellularComponent | tertiary granule | 4.91e-03 | 164 | 87 | 4 | GO:0070820 | |
| GeneOntologyCellularComponent | vacuolar membrane | 5.21e-03 | 507 | 87 | 7 | GO:0005774 | |
| GeneOntologyCellularComponent | specific granule membrane | 6.50e-03 | 91 | 87 | 3 | GO:0035579 | |
| GeneOntologyCellularComponent | endolysosome | 6.91e-03 | 30 | 87 | 2 | GO:0036019 | |
| MousePheno | abnormal skeletal muscle triglyceride level | PSG1 PSG3 PSG4 PSG6 PSG9 SLC27A1 CEACAM8 CEACAM6 PSG8 CEACAM1 | 2.79e-16 | 31 | 72 | 10 | MP:0031413 |
| MousePheno | increased skeletal muscle triglyceride level | 4.25e-16 | 21 | 72 | 9 | MP:0031415 | |
| MousePheno | abnormal muscle triglyceride level | PSG1 PSG3 PSG4 PSG6 PSG9 SLC27A1 CEACAM8 CEACAM6 PSG8 CEACAM1 | 1.57e-15 | 36 | 72 | 10 | MP:0031412 |
| MousePheno | decreased fatty acid oxidation | 1.87e-15 | 24 | 72 | 9 | MP:0014172 | |
| MousePheno | increased abdominal fat pad weight | 6.62e-15 | 27 | 72 | 9 | MP:0009286 | |
| MousePheno | decreased susceptibility to Coronaviridae infection induced morbidity/mortality | 7.77e-15 | 17 | 72 | 8 | MP:0031047 | |
| MousePheno | decreased carbon dioxide production | 2.80e-14 | 31 | 72 | 9 | MP:0008964 | |
| MousePheno | abnormal skeletal muscle cell glucose uptake | PSG1 PSG3 PSG4 PSG6 PSG9 SLC27A1 CEACAM8 CEACAM6 PSG8 CEACAM1 | 3.05e-14 | 47 | 72 | 10 | MP:0031617 |
| MousePheno | decreased skeletal muscle cell glucose uptake | 9.65e-14 | 35 | 72 | 9 | MP:0031618 | |
| MousePheno | decreased muscle cell glucose uptake | 2.85e-13 | 39 | 72 | 9 | MP:0030022 | |
| MousePheno | decreased susceptibility to Coronaviridae infection | 9.50e-13 | 28 | 72 | 8 | MP:0020950 | |
| MousePheno | abnormal muscle cell glucose uptake | PSG1 PSG3 PSG4 PSG6 PSG9 SLC27A1 CEACAM8 CEACAM6 PSG8 CEACAM1 | 1.35e-12 | 67 | 72 | 10 | MP:0004130 |
| MousePheno | abnormal carbon dioxide production | 1.35e-12 | 67 | 72 | 10 | MP:0008962 | |
| MousePheno | abnormal susceptibility to Coronaviridae infection | 2.65e-12 | 49 | 72 | 9 | MP:0020948 | |
| MousePheno | decreased cellular glucose uptake | 5.63e-12 | 53 | 72 | 9 | MP:0003926 | |
| MousePheno | abnormal fatty acid oxidation | 6.73e-12 | 54 | 72 | 9 | MP:0010953 | |
| MousePheno | decreased oxygen consumption | 7.46e-12 | 79 | 72 | 10 | MP:0005290 | |
| MousePheno | abnormal lipid oxidation | 2.13e-11 | 61 | 72 | 9 | MP:0010951 | |
| MousePheno | increased insulin secretion | 3.34e-11 | 64 | 72 | 9 | MP:0003058 | |
| MousePheno | decreased susceptibility to Riboviria infection induced morbidity/mortality | 5.07e-11 | 44 | 72 | 8 | MP:0031023 | |
| MousePheno | abnormal cellular glucose uptake | PSG1 PSG3 PSG4 PSG6 PSG9 SLC27A1 CEACAM8 CEACAM6 PSG8 CEACAM1 | 1.01e-10 | 102 | 72 | 10 | MP:0003925 |
| MousePheno | polyphagia | 2.64e-10 | 80 | 72 | 9 | MP:0001433 | |
| MousePheno | decreased energy expenditure | 4.69e-10 | 119 | 72 | 10 | MP:0004890 | |
| MousePheno | decreased susceptibility to viral infection induced morbidity/mortality | 6.86e-10 | 60 | 72 | 8 | MP:0009790 | |
| MousePheno | abnormal vascular wound healing | 3.42e-09 | 73 | 72 | 8 | MP:0004883 | |
| MousePheno | decreased respiratory quotient | 4.68e-09 | 110 | 72 | 9 | MP:0010379 | |
| MousePheno | obese | 5.94e-09 | 113 | 72 | 9 | MP:0001261 | |
| MousePheno | decreased susceptibility to Riboviria infection | 8.74e-09 | 82 | 72 | 8 | MP:0020914 | |
| MousePheno | decreased susceptibility to infection induced morbidity/mortality | 1.01e-08 | 120 | 72 | 9 | MP:0009786 | |
| MousePheno | increased circulating leptin level | 1.45e-08 | 125 | 72 | 9 | MP:0005669 | |
| MousePheno | abnormal respiratory quotient | 2.36e-08 | 178 | 72 | 10 | MP:0004129 | |
| MousePheno | abnormal glycogen homeostasis | 4.98e-08 | 144 | 72 | 9 | MP:0005438 | |
| MousePheno | abnormal oxygen consumption | 5.61e-08 | 195 | 72 | 10 | MP:0005288 | |
| MousePheno | insulin resistance | PSG1 PSG3 PSG4 PSG6 PSG9 CEACAM8 CEACAM6 PSG8 PDPK2P CEACAM1 | 6.17e-08 | 197 | 72 | 10 | MP:0005331 |
| MousePheno | decreased circulating triglyceride level | CACNA1B PSG1 PSG3 PSG4 PSG6 PSG9 HPN CEACAM8 CEACAM6 PSG8 CEACAM1 | 1.46e-07 | 275 | 72 | 11 | MP:0002644 |
| MousePheno | abnormal susceptibility to infection induced morbidity/mortality | MRC1 PSG1 PSG3 PSG4 PSG6 PSG9 CEACAM6 PSG8 TLR9 STAT1 CEACAM1 | 1.69e-07 | 279 | 72 | 11 | MP:0009785 |
| MousePheno | increased circulating insulin level | GPBAR1 PSG1 PSG3 PSG4 PSG6 PSG9 CEACAM8 CEACAM6 PSG8 PDPK2P CEACAM1 | 1.95e-07 | 283 | 72 | 11 | MP:0002079 |
| MousePheno | abnormal insulin secretion | 2.18e-07 | 171 | 72 | 9 | MP:0003564 | |
| MousePheno | decreased susceptibility to viral infection | 2.42e-07 | 125 | 72 | 8 | MP:0002410 | |
| MousePheno | abnormal pancreas physiology | PSG1 PSG3 PSG4 PSG6 PSG9 CEACAM8 CTRC CEACAM6 PSG8 CTSB CEACAM1 | 2.67e-07 | 292 | 72 | 11 | MP:0002693 |
| MousePheno | abnormal endocrine pancreas secretion | 2.79e-07 | 176 | 72 | 9 | MP:0014195 | |
| MousePheno | abnormal endocrine gland physiology | NOG PSG1 PSG3 PSG4 PSG6 PSG9 HPN CEACAM8 CEACAM6 PSG8 MDM4 CEACAM1 | 2.96e-07 | 363 | 72 | 12 | MP:0013561 |
| MousePheno | abnormal circulating leptin level | CACNA1B PSG1 PSG3 PSG4 PSG6 PSG9 CEACAM8 CEACAM6 PSG8 CEACAM1 | 3.33e-07 | 236 | 72 | 10 | MP:0005667 |
| MousePheno | abnormal pancreas secretion | 3.88e-07 | 183 | 72 | 9 | MP:0002694 | |
| MousePheno | abnormal susceptibility to Riboviria infection | 4.45e-07 | 186 | 72 | 9 | MP:0020912 | |
| MousePheno | increased food intake | 5.10e-07 | 189 | 72 | 9 | MP:0011939 | |
| MousePheno | abnormal energy expenditure | CACNA1B PSG1 PSG3 PSG4 PSG6 OPN3 PSG9 CEACAM8 CEACAM6 PSG8 CEACAM1 | 5.33e-07 | 313 | 72 | 11 | MP:0005450 |
| MousePheno | abnormal intestine morphology | PSG1 PSG3 PSG4 PSG6 PSG9 WNT3A CTRC LAMA5 CEACAM6 PSG8 FUT8 SOAT2 STAT1 CEACAM1 | 6.03e-07 | 546 | 72 | 14 | MP:0000477 |
| MousePheno | increased incidence of tumors by chemical induction | 6.10e-07 | 141 | 72 | 8 | MP:0004499 | |
| MousePheno | decreased susceptibility to infection | 6.79e-07 | 255 | 72 | 10 | MP:0002409 | |
| MousePheno | abnormal pancreatic beta cell physiology | 6.92e-07 | 196 | 72 | 9 | MP:0003562 | |
| MousePheno | abnormal energy homeostasis | CACNA1B PSG1 PSG3 PSG4 PSG6 OPN3 PSG9 CEACAM8 CEACAM6 PSG8 CEACAM1 | 7.05e-07 | 322 | 72 | 11 | MP:0005448 |
| MousePheno | abnormal induced morbidity/mortality | CACNA1A MRC1 PSG1 PSG3 PSG4 PSG6 PSG9 A4GALT LAMA3 CEACAM6 PSG8 TLR9 MDM4 STAT1 RYR1 CEACAM1 | 7.79e-07 | 737 | 72 | 16 | MP:0001657 |
| MousePheno | abnormal endocrine pancreas physiology | 8.91e-07 | 202 | 72 | 9 | MP:0010147 | |
| MousePheno | abnormal colon morphology | 1.08e-06 | 152 | 72 | 8 | MP:0000495 | |
| MousePheno | decreased triglyceride level | CACNA1B PSG1 PSG3 PSG4 PSG6 PSG9 HPN CEACAM8 CEACAM6 PSG8 CEACAM1 | 1.51e-06 | 348 | 72 | 11 | MP:0005318 |
| MousePheno | abnormal susceptibility to viral infection | 1.54e-06 | 279 | 72 | 10 | MP:0020185 | |
| MousePheno | increased triglyceride level | PSG1 PSG3 PSG4 PSG6 PSG9 WNT3A CEACAM8 CEACAM6 PSG8 SOAT2 CEACAM1 | 1.78e-06 | 354 | 72 | 11 | MP:0005317 |
| MousePheno | abnormal gland physiology | NOG PSG1 PSG3 PSG4 PSG6 PSG9 HPN CEACAM8 CTRC CEACAM6 PSG8 MDM4 CTSB ALK CEACAM1 | 1.84e-06 | 691 | 72 | 15 | MP:0002164 |
| MousePheno | abnormal gas homeostasis | PSG1 PSG3 PSG4 PSG6 OPN3 PSG9 CEACAM8 LRP2 CEACAM6 PSG8 TNRC6C STAT1 RYR1 CEACAM1 | 1.85e-06 | 600 | 72 | 14 | MP:0003948 |
| MousePheno | abnormal circulating triglyceride level | CACNA1B PSG1 PSG3 PSG4 PSG6 PSG9 HPN WNT3A CEACAM8 CEACAM6 PSG8 SOAT2 CEACAM1 | 1.96e-06 | 516 | 72 | 13 | MP:0011969 |
| MousePheno | abnormal digestive system morphology | NOG PSG1 PSG3 PSG4 PSG6 PSG9 WNT3A CTRC LRP2 LAMA3 LAMA5 CEACAM6 CC2D2A TBXT PSG8 FUT8 SOAT2 STAT1 RYR1 CEACAM1 | 2.51e-06 | 1233 | 72 | 20 | MP:0000462 |
| MousePheno | increased incidence of induced tumors | 2.85e-06 | 173 | 72 | 8 | MP:0002021 | |
| MousePheno | digestive/alimentary phenotype | NOG PSG1 PSG3 PSG4 PSG6 PSG9 WNT3A CTRC LRP2 LAMA3 LAMA5 CEACAM6 CC2D2A TBXT PSG8 TLR9 FUT8 CTSB SOAT2 STAT1 RYR1 CEACAM1 | 3.62e-06 | 1500 | 72 | 22 | MP:0005381 |
| MousePheno | abnormal triglyceride level | CACNA1B PSG1 PSG3 PSG4 PSG6 PSG9 HPN SLC27A1 WNT3A CEACAM8 CEACAM6 PSG8 SOAT2 CEACAM1 | 3.86e-06 | 639 | 72 | 14 | MP:0000187 |
| MousePheno | increased hormone level | CACNA1A GPBAR1 MRC1 PSG1 PSG3 PSG4 PSG6 PSG9 CEACAM8 LRP2 CEACAM6 PSG8 PDPK2P CEACAM1 | 4.00e-06 | 641 | 72 | 14 | MP:0014454 |
| MousePheno | vestigial tail | 4.52e-06 | 7 | 72 | 3 | MP:0002632 | |
| MousePheno | abnormal hormone level | CACNA1A CACNA1B GPBAR1 MRC1 PSG1 PSG3 PSG4 PSG6 PSG9 HPN CEACAM8 LRP2 CEACAM6 PSG8 PDPK2P CTSB ALK CEACAM1 | 5.73e-06 | 1073 | 72 | 18 | MP:0003953 |
| MousePheno | abnormal physiological response to xenobiotic | CACNA1A GPBAR1 PSG1 PSG3 PSG4 PSG6 PSG9 A4GALT SLC35E1 CEACAM6 PSG8 STAT1 RYR1 CEACAM1 | 5.80e-06 | 662 | 72 | 14 | MP:0008872 |
| MousePheno | abnormal wound healing | 6.42e-06 | 193 | 72 | 8 | MP:0005023 | |
| MousePheno | increased circulating hormone level | GPBAR1 MRC1 PSG1 PSG3 PSG4 PSG6 PSG9 CEACAM8 LRP2 CEACAM6 PSG8 PDPK2P CEACAM1 | 6.78e-06 | 578 | 72 | 13 | MP:0014456 |
| MousePheno | increased body size | PSG1 PSG3 PSG4 PSG6 PSG9 CEACAM8 CEACAM6 LTA4H PSG8 RYR1 CEACAM1 | 7.14e-06 | 409 | 72 | 11 | MP:0001264 |
| MousePheno | abnormal abdominal fat pad morphology | 7.55e-06 | 262 | 72 | 9 | MP:0000010 | |
| MousePheno | abnormal circulating insulin level | CACNA1B GPBAR1 PSG1 PSG3 PSG4 PSG6 PSG9 CEACAM8 CEACAM6 PSG8 PDPK2P CEACAM1 | 9.25e-06 | 505 | 72 | 12 | MP:0001560 |
| MousePheno | abnormal large intestine morphology | 1.15e-05 | 276 | 72 | 9 | MP:0000489 | |
| MousePheno | increased physiological sensitivity to xenobiotic | 1.52e-05 | 286 | 72 | 9 | MP:0008873 | |
| MousePheno | increased total tissue mass | 1.61e-05 | 364 | 72 | 10 | MP:0012323 | |
| MousePheno | increased body weight | 1.61e-05 | 364 | 72 | 10 | MP:0001260 | |
| MousePheno | abnormal tumor incidence | PLA2R1 PSG1 PSG3 PSG4 PSG6 PSG9 CEACAM6 POLD4 ATP11A PSG8 FUT8 STAT1 CEACAM1 | 1.85e-05 | 635 | 72 | 13 | MP:0002019 |
| MousePheno | absent tail | 2.10e-05 | 11 | 72 | 3 | MP:0003456 | |
| MousePheno | abnormal tumor susceptibility | PLA2R1 PSG1 PSG3 PSG4 PSG6 PSG9 CEACAM6 POLD4 ATP11A PSG8 FUT8 STAT1 CEACAM1 | 2.37e-05 | 650 | 72 | 13 | MP:0002166 |
| MousePheno | decreased ventral ectodermal ridge size | 2.62e-05 | 2 | 72 | 2 | MP:0012714 | |
| MousePheno | abnormal ventral ectodermal ridge morphology | 2.62e-05 | 2 | 72 | 2 | MP:0012713 | |
| MousePheno | absent tail bud | 2.62e-05 | 2 | 72 | 2 | MP:0012063 | |
| MousePheno | impaired glucose tolerance | GPBAR1 PSG1 PSG3 PSG4 PSG6 PSG9 CEACAM8 CEACAM6 PSG8 PDPK2P CEACAM1 | 3.17e-05 | 480 | 72 | 11 | MP:0005293 |
| MousePheno | abnormal fat pad morphology | 3.19e-05 | 314 | 72 | 9 | MP:0005334 | |
| MousePheno | abnormal food intake | PSG1 PSG3 PSG4 PSG6 OPN3 PSG9 CEACAM8 CEACAM6 PSG8 ALK CEACAM1 | 3.24e-05 | 481 | 72 | 11 | MP:0005449 |
| MousePheno | abnormal skeletal muscle morphology | PSG1 PSG3 PSG4 PSG6 PSG9 SLC27A1 CEACAM8 CEACAM6 PSG8 RYR1 CEACAM1 | 5.32e-05 | 508 | 72 | 11 | MP:0000759 |
| MousePheno | increased total body fat amount | 5.92e-05 | 424 | 72 | 10 | MP:0010024 | |
| MousePheno | abnormal rostral-caudal axis patterning | 5.93e-05 | 132 | 72 | 6 | MP:0005221 | |
| MousePheno | abnormal incidence of induced tumors | 6.99e-05 | 269 | 72 | 8 | MP:0013151 | |
| MousePheno | increased tumor incidence | PLA2R1 PSG1 PSG3 PSG4 PSG6 PSG9 CEACAM6 ATP11A PSG8 STAT1 CEACAM1 | 7.78e-05 | 530 | 72 | 11 | MP:0002020 |
| MousePheno | increased lean body mass | 8.07e-05 | 354 | 72 | 9 | MP:0003960 | |
| MousePheno | abnormal circulating hormone level | CACNA1B GPBAR1 MRC1 PSG1 PSG3 PSG4 PSG6 PSG9 CEACAM8 LRP2 CEACAM6 PSG8 PDPK2P ALK CEACAM1 | 8.48e-05 | 954 | 72 | 15 | MP:0005418 |
| MousePheno | neoplasm | PLA2R1 PSG1 PSG3 PSG4 PSG6 PSG9 CEACAM6 POLD4 ATP11A PSG8 FUT8 STAT1 CEACAM1 | 9.92e-05 | 747 | 72 | 13 | MP:0002006 |
| MousePheno | failure of somite differentiation | 1.25e-04 | 50 | 72 | 4 | MP:0001690 | |
| MousePheno | abnormal consumption behavior | CACNA1B PSG1 PSG3 PSG4 PSG6 OPN3 PSG9 CEACAM8 CEACAM6 PSG8 ALK CEACAM1 | 2.05e-04 | 695 | 72 | 12 | MP:0002069 |
| MousePheno | abnormal eating behavior | PSG1 PSG3 PSG4 PSG6 OPN3 PSG9 CEACAM8 CEACAM6 PSG8 ALK CEACAM1 | 2.45e-04 | 604 | 72 | 11 | MP:0001431 |
| MousePheno | abnormal response to injury | CACNA1A PSG1 PSG3 PSG4 PSG6 PSG9 LAMA3 CEACAM6 PSG8 STAT1 CEACAM1 | 2.56e-04 | 607 | 72 | 11 | MP:0005164 |
| MousePheno | decreased lipid level | CACNA1B PSG1 PSG3 PSG4 PSG6 PSG9 HPN CEACAM8 CEACAM6 PSG8 SOAT2 CEACAM1 | 3.09e-04 | 727 | 72 | 12 | MP:0014461 |
| Domain | Ig_2 | PSG1 PSG3 PSG4 PSG6 PSG7 PSG9 CEACAM8 CEACAM6 PSG8 FCRL4 CEACAM1 | 2.87e-14 | 73 | 86 | 11 | PF13895 |
| Domain | IGc2 | MYOM1 PSG1 PSG3 PSG4 PSG6 PSG7 PSG9 CEACAM8 CEACAM6 PSG8 FCRL4 KIRREL2 CNTN6 CEACAM1 | 3.44e-12 | 235 | 86 | 14 | SM00408 |
| Domain | Ig_sub2 | MYOM1 PSG1 PSG3 PSG4 PSG6 PSG7 PSG9 CEACAM8 CEACAM6 PSG8 FCRL4 KIRREL2 CNTN6 CEACAM1 | 3.44e-12 | 235 | 86 | 14 | IPR003598 |
| Domain | V-set | PSG1 PSG3 PSG4 PSG6 PSG7 PSG9 CEACAM8 CEACAM6 PSG8 KIRREL2 BTNL9 CEACAM1 | 4.73e-11 | 184 | 86 | 12 | PF07686 |
| Domain | ig | MYOM1 PSG1 PSG3 PSG4 PSG6 PSG7 PSG9 CEACAM8 CEACAM6 PSG8 FCRL4 CEACAM1 | 6.87e-11 | 190 | 86 | 12 | PF00047 |
| Domain | Immunoglobulin | MYOM1 PSG1 PSG3 PSG4 PSG6 PSG7 PSG9 CEACAM8 CEACAM6 PSG8 FCRL4 CEACAM1 | 6.87e-11 | 190 | 86 | 12 | IPR013151 |
| Domain | IG_LIKE | CD1B MYOM1 PSG1 PSG3 PSG4 PSG6 PSG7 PSG9 CEACAM8 CEACAM6 MICA PSG8 FCRL4 KIRREL2 BTNL9 CNTN6 CEACAM1 | 7.77e-11 | 491 | 86 | 17 | PS50835 |
| Domain | Ig-like_dom | CD1B MYOM1 PSG1 PSG3 PSG4 PSG6 PSG7 PSG9 CEACAM8 CEACAM6 MICA PSG8 FCRL4 KIRREL2 BTNL9 CNTN6 CEACAM1 | 1.13e-10 | 503 | 86 | 17 | IPR007110 |
| Domain | Ig_V-set | PSG1 PSG3 PSG4 PSG6 PSG7 PSG9 CEACAM8 CEACAM6 PSG8 KIRREL2 BTNL9 CEACAM1 | 1.18e-10 | 199 | 86 | 12 | IPR013106 |
| Domain | IG | MYOM1 PSG1 PSG3 PSG4 PSG6 PSG7 PSG9 CEACAM8 CEACAM6 PSG8 FCRL4 KIRREL2 BTNL9 CNTN6 CEACAM1 | 7.78e-10 | 421 | 86 | 15 | SM00409 |
| Domain | Ig_sub | MYOM1 PSG1 PSG3 PSG4 PSG6 PSG7 PSG9 CEACAM8 CEACAM6 PSG8 FCRL4 KIRREL2 BTNL9 CNTN6 CEACAM1 | 7.78e-10 | 421 | 86 | 15 | IPR003599 |
| Domain | - | CD1B MYOM1 PSG1 PSG3 PSG4 PSG6 PSG7 PSG9 CEACAM8 CEACAM6 MICA PSG8 FCRL4 KIRREL2 BTNL9 CNTN6 CEACAM1 | 7.46e-09 | 663 | 86 | 17 | 2.60.40.10 |
| Domain | Ig-like_fold | CD1B MYOM1 PSG1 PSG3 PSG4 PSG6 PSG7 PSG9 CEACAM8 CEACAM6 MICA PSG8 FCRL4 KIRREL2 BTNL9 CNTN6 CEACAM1 | 1.88e-08 | 706 | 86 | 17 | IPR013783 |
| Domain | Kringle-like | 1.37e-05 | 32 | 86 | 4 | IPR013806 | |
| Domain | Wnt3 | 2.10e-05 | 2 | 86 | 2 | IPR009141 | |
| Domain | - | 2.61e-05 | 13 | 86 | 3 | 2.10.10.10 | |
| Domain | FN_type2_col-bd | 3.31e-05 | 14 | 86 | 3 | IPR000562 | |
| Domain | FN2_2 | 3.31e-05 | 14 | 86 | 3 | PS51092 | |
| Domain | fn2 | 3.31e-05 | 14 | 86 | 3 | PF00040 | |
| Domain | FN2_1 | 3.31e-05 | 14 | 86 | 3 | PS00023 | |
| Domain | FN2 | 3.31e-05 | 14 | 86 | 3 | SM00059 | |
| Domain | Laminin_aI | 2.08e-04 | 5 | 86 | 2 | IPR009254 | |
| Domain | Laminin_I | 2.08e-04 | 5 | 86 | 2 | PF06008 | |
| Domain | Laminin_II | 2.08e-04 | 5 | 86 | 2 | PF06009 | |
| Domain | Laminin_domII | 2.08e-04 | 5 | 86 | 2 | IPR010307 | |
| Domain | Hyaluronidase | 2.08e-04 | 5 | 86 | 2 | IPR018155 | |
| Domain | Glyco_hydro_56 | 2.08e-04 | 5 | 86 | 2 | PF01630 | |
| Domain | Ig_I-set | 2.45e-04 | 190 | 86 | 6 | IPR013098 | |
| Domain | I-set | 2.45e-04 | 190 | 86 | 6 | PF07679 | |
| Domain | RICIN | 2.84e-04 | 28 | 86 | 3 | SM00458 | |
| Domain | RICIN_B_LECTIN | 2.84e-04 | 28 | 86 | 3 | PS50231 | |
| Domain | Liprin | 3.11e-04 | 6 | 86 | 2 | IPR029515 | |
| Domain | Ricin_B_lectin | 3.50e-04 | 30 | 86 | 3 | IPR000772 | |
| Domain | VDCC_a1su_IQ | 4.34e-04 | 7 | 86 | 2 | IPR014873 | |
| Domain | GPHH | 4.34e-04 | 7 | 86 | 2 | PF16905 | |
| Domain | GPHH_dom | 4.34e-04 | 7 | 86 | 2 | IPR031649 | |
| Domain | Ca_chan_IQ | 4.34e-04 | 7 | 86 | 2 | SM01062 | |
| Domain | Ca_chan_IQ | 4.34e-04 | 7 | 86 | 2 | PF08763 | |
| Domain | LAMININ_IVA | 5.76e-04 | 8 | 86 | 2 | PS51115 | |
| Domain | Laminin_B | 5.76e-04 | 8 | 86 | 2 | PF00052 | |
| Domain | LamB | 5.76e-04 | 8 | 86 | 2 | SM00281 | |
| Domain | Laminin_IV | 5.76e-04 | 8 | 86 | 2 | IPR000034 | |
| Domain | EGF | 7.56e-04 | 235 | 86 | 6 | SM00181 | |
| Domain | VDCCAlpha1 | 9.21e-04 | 10 | 86 | 2 | IPR002077 | |
| Domain | - | 9.50e-04 | 42 | 86 | 3 | 3.20.20.70 | |
| Domain | C-type_lectin_CS | 1.02e-03 | 43 | 86 | 3 | IPR018378 | |
| Domain | Aldolase_TIM | 1.09e-03 | 44 | 86 | 3 | IPR013785 | |
| Domain | EGF_1 | 1.15e-03 | 255 | 86 | 6 | PS00022 | |
| Domain | EGF_2 | 1.40e-03 | 265 | 86 | 6 | PS01186 | |
| Domain | Glycoside_hydrolase_SF | 1.87e-03 | 53 | 86 | 3 | IPR017853 | |
| Domain | Laminin_N | 2.41e-03 | 16 | 86 | 2 | IPR008211 | |
| Domain | LAMININ_NTER | 2.41e-03 | 16 | 86 | 2 | PS51117 | |
| Domain | Laminin_N | 2.41e-03 | 16 | 86 | 2 | PF00055 | |
| Domain | LamNT | 2.41e-03 | 16 | 86 | 2 | SM00136 | |
| Domain | Wnt | 3.41e-03 | 19 | 86 | 2 | IPR005817 | |
| Domain | Wnt_CS | 3.41e-03 | 19 | 86 | 2 | IPR018161 | |
| Domain | wnt | 3.41e-03 | 19 | 86 | 2 | PF00110 | |
| Domain | WNT1 | 3.41e-03 | 19 | 86 | 2 | SM00097 | |
| Domain | WNT1 | 3.41e-03 | 19 | 86 | 2 | PS00246 | |
| Domain | ConA-like_dom | 3.42e-03 | 219 | 86 | 5 | IPR013320 | |
| Pathway | REACTOME_POST_TRANSLATIONAL_MODIFICATION_SYNTHESIS_OF_GPI_ANCHORED_PROTEINS | 7.91e-11 | 99 | 73 | 10 | MM14624 | |
| Pathway | REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL | 5.66e-08 | 194 | 73 | 10 | M16312 | |
| Pathway | REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL | 1.17e-07 | 158 | 73 | 9 | MM14812 | |
| Pathway | WP_EGFR1_SIGNALING_PATHWAY | 5.13e-07 | 188 | 73 | 9 | MM15828 | |
| Pathway | REACTOME_FIBRONECTIN_MATRIX_FORMATION | 2.64e-06 | 6 | 73 | 3 | M26970 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 7.00e-06 | 258 | 73 | 9 | MM14572 | |
| Pathway | REACTOME_NEUTROPHIL_DEGRANULATION | PSG1 PSG3 PSG4 PSG6 PSG9 CEACAM8 CEACAM6 LTA4H ATP11A PSG8 CTSB CEACAM1 | 1.11e-05 | 511 | 73 | 12 | MM15330 |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 2.13e-05 | 11 | 73 | 3 | M47958 | |
| Pubmed | 6.83e-21 | 14 | 90 | 9 | 11994468 | ||
| Pubmed | 6.83e-21 | 14 | 90 | 9 | 20381490 | ||
| Pubmed | 6.83e-21 | 14 | 90 | 9 | 22159884 | ||
| Pubmed | 6.83e-21 | 14 | 90 | 9 | 28567513 | ||
| Pubmed | 6.83e-21 | 14 | 90 | 9 | 8207827 | ||
| Pubmed | CEACAM2 positively regulates integrin αIIbβ3-mediated platelet functions. | 6.83e-21 | 14 | 90 | 9 | 27161904 | |
| Pubmed | 6.83e-21 | 14 | 90 | 9 | 23070997 | ||
| Pubmed | 6.83e-21 | 14 | 90 | 9 | 10491101 | ||
| Pubmed | 1.70e-20 | 15 | 90 | 9 | 24948196 | ||
| Pubmed | 1.70e-20 | 15 | 90 | 9 | 20410265 | ||
| Pubmed | 1.70e-20 | 15 | 90 | 9 | 26586918 | ||
| Pubmed | 3.88e-20 | 16 | 90 | 9 | 25085348 | ||
| Pubmed | Differences in tissue-specific and embryonic expression of mouse Ceacam1 and Ceacam2 genes. | 3.88e-20 | 16 | 90 | 9 | 11284729 | |
| Pubmed | A mouse carcinoembryonic antigen gene family member is a calcium-dependent cell adhesion molecule. | 1.86e-18 | 13 | 90 | 8 | 1985902 | |
| Pubmed | CEACAM1+ myeloid cells control angiogenesis in inflammation. | 1.86e-18 | 13 | 90 | 8 | 19273835 | |
| Pubmed | Mechanism of glucose intolerance in mice with dominant negative mutation of CEACAM1. | 1.86e-18 | 13 | 90 | 8 | 16638824 | |
| Pubmed | 1.86e-18 | 13 | 90 | 8 | 20044046 | ||
| Pubmed | 1.86e-18 | 13 | 90 | 8 | 32150576 | ||
| Pubmed | 1.86e-18 | 13 | 90 | 8 | 6265583 | ||
| Pubmed | 1.86e-18 | 13 | 90 | 8 | 34440862 | ||
| Pubmed | CEACAM1 is a potent regulator of B cell receptor complex-induced activation. | 1.86e-18 | 13 | 90 | 8 | 12832451 | |
| Pubmed | 1.86e-18 | 13 | 90 | 8 | 25406283 | ||
| Pubmed | Crystal structure of mouse coronavirus receptor-binding domain complexed with its murine receptor. | 1.86e-18 | 13 | 90 | 8 | 21670291 | |
| Pubmed | 1.86e-18 | 13 | 90 | 8 | 22162753 | ||
| Pubmed | 1.86e-18 | 13 | 90 | 8 | 2702644 | ||
| Pubmed | 1.86e-18 | 13 | 90 | 8 | 8380065 | ||
| Pubmed | 1.86e-18 | 13 | 90 | 8 | 1279194 | ||
| Pubmed | 1.86e-18 | 13 | 90 | 8 | 25724769 | ||
| Pubmed | 1.86e-18 | 13 | 90 | 8 | 26374765 | ||
| Pubmed | CEACAM1 deficiency delays important wound healing processes. | 1.86e-18 | 13 | 90 | 8 | 22092845 | |
| Pubmed | 1.86e-18 | 13 | 90 | 8 | 11801635 | ||
| Pubmed | 1.86e-18 | 13 | 90 | 8 | 28913658 | ||
| Pubmed | Expression of the Bgp gene and characterization of mouse colon biliary glycoprotein isoforms. | 1.86e-18 | 13 | 90 | 8 | 8500759 | |
| Pubmed | Mouse susceptibility to mouse hepatitis virus infection is linked to viral receptor genotype. | 1.86e-18 | 13 | 90 | 8 | 9343248 | |
| Pubmed | Ceacam1 deletion causes vascular alterations in large vessels. | 1.86e-18 | 13 | 90 | 8 | 23800882 | |
| Pubmed | 1.86e-18 | 13 | 90 | 8 | 19285068 | ||
| Pubmed | 1.86e-18 | 13 | 90 | 8 | 21760897 | ||
| Pubmed | 1.86e-18 | 13 | 90 | 8 | 1719235 | ||
| Pubmed | Mouse hepatitis virus utilizes two carcinoembryonic antigens as alternative receptors. | 1.86e-18 | 13 | 90 | 8 | 1326665 | |
| Pubmed | Conditional deletion of CEACAM1 in hepatic stellate cells causes their activation. | 1.86e-18 | 13 | 90 | 8 | 39168268 | |
| Pubmed | 1.86e-18 | 13 | 90 | 8 | 8402684 | ||
| Pubmed | 1.86e-18 | 13 | 90 | 8 | 16619040 | ||
| Pubmed | 1.86e-18 | 13 | 90 | 8 | 29377208 | ||
| Pubmed | Expression of MHV-A59 receptor glycoproteins in susceptible and resistant strains of mice. | 1.86e-18 | 13 | 90 | 8 | 8209741 | |
| Pubmed | 1.86e-18 | 13 | 90 | 8 | 27002145 | ||
| Pubmed | Mice with null mutation of Ceacam I develop nonalcoholic steatohepatitis. | 1.86e-18 | 13 | 90 | 8 | 21949477 | |
| Pubmed | 1.86e-18 | 13 | 90 | 8 | 26219866 | ||
| Pubmed | 1.86e-18 | 13 | 90 | 8 | 2133556 | ||
| Pubmed | 1.86e-18 | 13 | 90 | 8 | 32521208 | ||
| Pubmed | 1.86e-18 | 13 | 90 | 8 | 19406938 | ||
| Pubmed | 1.86e-18 | 13 | 90 | 8 | 19621080 | ||
| Pubmed | CEACAM1 promotes CD8+ T cell responses and improves control of a chronic viral infection. | 1.86e-18 | 13 | 90 | 8 | 29967450 | |
| Pubmed | Expression of newly identified secretory CEACAM1(a) isoforms in the intestinal epithelium. | 1.86e-18 | 13 | 90 | 8 | 19358828 | |
| Pubmed | 1.86e-18 | 13 | 90 | 8 | 16680193 | ||
| Pubmed | 1.86e-18 | 13 | 90 | 8 | 1653760 | ||
| Pubmed | Regulation of hepatic fibrosis by carcinoembryonic antigen-related cell adhesion molecule 1. | 1.86e-18 | 13 | 90 | 8 | 34058224 | |
| Pubmed | 1.86e-18 | 13 | 90 | 8 | 10964771 | ||
| Pubmed | 1.86e-18 | 13 | 90 | 8 | 32169849 | ||
| Pubmed | 1.86e-18 | 13 | 90 | 8 | 22469976 | ||
| Pubmed | CEACAM1 creates a pro-angiogenic tumor microenvironment that supports tumor vessel maturation. | 1.86e-18 | 13 | 90 | 8 | 21532628 | |
| Pubmed | Structural and Molecular Evidence Suggesting Coronavirus-driven Evolution of Mouse Receptor. | 1.86e-18 | 13 | 90 | 8 | 28035001 | |
| Pubmed | Interaction between altered insulin and lipid metabolism in CEACAM1-inactive transgenic mice. | 1.86e-18 | 13 | 90 | 8 | 15316023 | |
| Pubmed | In vivo adaptation and persistence of Neisseria meningitidis within the nasopharyngeal mucosa. | 1.86e-18 | 13 | 90 | 8 | 23935487 | |
| Pubmed | 1.86e-18 | 13 | 90 | 8 | 15331748 | ||
| Pubmed | 1.86e-18 | 13 | 90 | 8 | 22673933 | ||
| Pubmed | Tumor angiogenesis mediated by myeloid cells is negatively regulated by CEACAM1. | 1.86e-18 | 13 | 90 | 8 | 22406619 | |
| Pubmed | 1.86e-18 | 13 | 90 | 8 | 7628460 | ||
| Pubmed | Forced Hepatic Overexpression of CEACAM1 Curtails Diet-Induced Insulin Resistance. | 1.86e-18 | 13 | 90 | 8 | 25972571 | |
| Pubmed | 1.86e-18 | 13 | 90 | 8 | 19008452 | ||
| Pubmed | 1.86e-18 | 13 | 90 | 8 | 18544705 | ||
| Pubmed | Expression of the mouse hepatitis virus receptor by central nervous system microglia. | 1.86e-18 | 13 | 90 | 8 | 15220458 | |
| Pubmed | 1.86e-18 | 13 | 90 | 8 | 18843289 | ||
| Pubmed | 1.86e-18 | 13 | 90 | 8 | 15207636 | ||
| Pubmed | 1.86e-18 | 13 | 90 | 8 | 21081647 | ||
| Pubmed | 1.86e-18 | 13 | 90 | 8 | 11133662 | ||
| Pubmed | 1.86e-18 | 13 | 90 | 8 | 11483763 | ||
| Pubmed | 1.86e-18 | 13 | 90 | 8 | 2164599 | ||
| Pubmed | 1.86e-18 | 13 | 90 | 8 | 29396368 | ||
| Pubmed | 1.86e-18 | 13 | 90 | 8 | 18003729 | ||
| Pubmed | 1.86e-18 | 13 | 90 | 8 | 26284027 | ||
| Pubmed | CEACAM1 specifically suppresses B cell receptor signaling-mediated activation. | 1.86e-18 | 13 | 90 | 8 | 33352461 | |
| Pubmed | 1.86e-18 | 13 | 90 | 8 | 38381498 | ||
| Pubmed | 1.86e-18 | 13 | 90 | 8 | 20739537 | ||
| Pubmed | 1.86e-18 | 13 | 90 | 8 | 1633107 | ||
| Pubmed | The role of CEA-related cell adhesion molecule-1 (CEACAM1) in vascular homeostasis. | 1.86e-18 | 13 | 90 | 8 | 27695943 | |
| Pubmed | 1.86e-18 | 13 | 90 | 8 | 20404914 | ||
| Pubmed | 1.86e-18 | 13 | 90 | 8 | 26911181 | ||
| Pubmed | Hepatic CEACAM1 expression indicates donor liver quality and prevents early transplantation injury. | 1.86e-18 | 13 | 90 | 8 | 32027621 | |
| Pubmed | 1.86e-18 | 13 | 90 | 8 | 30664851 | ||
| Pubmed | Role for hepatic CEACAM1 in regulating fatty acid metabolism along the adipocyte-hepatocyte axis. | 1.86e-18 | 13 | 90 | 8 | 27777319 | |
| Pubmed | 1.86e-18 | 13 | 90 | 8 | 18848945 | ||
| Pubmed | 4.33e-18 | 14 | 90 | 8 | 37531413 | ||
| Pubmed | Human CEACAM1-LF regulates lipid storage in HepG2 cells via fatty acid transporter CD36. | 4.33e-18 | 14 | 90 | 8 | 34666041 | |
| Pubmed | 4.33e-18 | 14 | 90 | 8 | 34619794 | ||
| Pubmed | SHP1 phosphatase-dependent T cell inhibition by CEACAM1 adhesion molecule isoforms. | 4.33e-18 | 14 | 90 | 8 | 17081782 | |
| Pubmed | Loss of Ceacam1 promotes prostate cancer progression in Pten haploinsufficient male mice. | 4.33e-18 | 14 | 90 | 8 | 32209360 | |
| Pubmed | 4.33e-18 | 14 | 90 | 8 | 11850617 | ||
| Pubmed | CEACAM1 regulates integrin αIIbβ3-mediated functions in platelets. | 4.33e-18 | 14 | 90 | 8 | 26196244 | |
| Pubmed | 4.33e-18 | 14 | 90 | 8 | 8896983 | ||
| Pubmed | 4.33e-18 | 14 | 90 | 8 | 22962327 | ||
| Interaction | CEACAM7 interactions | 1.12e-08 | 7 | 87 | 4 | int:CEACAM7 | |
| Interaction | PSG4 interactions | 2.24e-08 | 8 | 87 | 4 | int:PSG4 | |
| Interaction | PSG1 interactions | 8.37e-08 | 51 | 87 | 6 | int:PSG1 | |
| Interaction | PSG3 interactions | 2.23e-06 | 22 | 87 | 4 | int:PSG3 | |
| Interaction | SDF2L1 interactions | 1.04e-05 | 322 | 87 | 9 | int:SDF2L1 | |
| Interaction | NOMO1 interactions | 1.34e-05 | 181 | 87 | 7 | int:NOMO1 | |
| Interaction | OS9 interactions | 4.55e-05 | 219 | 87 | 7 | int:OS9 | |
| Interaction | CELSR3 interactions | 4.60e-05 | 46 | 87 | 4 | int:CELSR3 | |
| Interaction | CEACAM1 interactions | 9.77e-05 | 21 | 87 | 3 | int:CEACAM1 | |
| Interaction | MEGF8 interactions | 1.00e-04 | 56 | 87 | 4 | int:MEGF8 | |
| Interaction | PSG6 interactions | 1.10e-04 | 4 | 87 | 2 | int:PSG6 | |
| Interaction | PSG9 interactions | 1.13e-04 | 22 | 87 | 3 | int:PSG9 | |
| Cytoband | 19q13.2 | PSG1 PSG3 PSG4 PSG6 PSG7 PSG9 CEACAM8 CEACAM6 PSG8 CEACAM1 B3GNT8 | 2.81e-14 | 164 | 90 | 11 | 19q13.2 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | PSG1 PSG3 PSG4 PSG6 PSG7 PSG9 HPN CEACAM8 NKPD1 CEACAM6 PSG8 PPFIA3 KIRREL2 RYR1 CEACAM1 B3GNT8 | 1.37e-09 | 1192 | 90 | 16 | chr19q13 |
| Cytoband | 2p23 | 5.07e-04 | 17 | 90 | 2 | 2p23 | |
| GeneFamily | CD molecules|V-set domain containing|Pregnancy specific glycoproteins | 8.90e-16 | 11 | 59 | 7 | 1315 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 1.15e-10 | 163 | 59 | 10 | 590 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 5.23e-07 | 394 | 59 | 10 | 471 | |
| GeneFamily | CD molecules|V-set domain containing|Immunoglobulin like domain containing|Carcinoembryonic antigen related cell adhesion molecule family | 6.36e-05 | 24 | 59 | 3 | 906 | |
| GeneFamily | Immunoglobulin like domain containing | 4.13e-04 | 193 | 59 | 5 | 594 | |
| GeneFamily | C-type lectin domain family | 4.83e-04 | 47 | 59 | 3 | 494 | |
| GeneFamily | Laminin subunits | 6.77e-04 | 12 | 59 | 2 | 626 | |
| GeneFamily | Wnt family|Endogenous ligands | 1.73e-03 | 19 | 59 | 2 | 360 | |
| GeneFamily | Calcium voltage-gated channel subunits | 3.24e-03 | 26 | 59 | 2 | 253 | |
| GeneFamily | C1-set domain containing | 8.29e-03 | 42 | 59 | 2 | 591 | |
| Coexpression | OUYANG_PROSTATE_CANCER_MARKERS | 2.33e-17 | 35 | 90 | 10 | MM757 | |
| Coexpression | GIBBONS_GENETIC_MOUSE_MODEL_LUNG_ADENOCARCINOMA_DOWN_IN_METASTASIS | 1.38e-13 | 32 | 90 | 8 | MM2 | |
| Coexpression | BOYLAN_MULTIPLE_MYELOMA_PCA3_DN | 4.39e-13 | 87 | 90 | 10 | MM851 | |
| Coexpression | BYSTROEM_CORRELATED_WITH_IL5_DN | 4.59e-12 | 75 | 90 | 9 | MM605 | |
| Coexpression | WANG_RESPONSE_TO_BEXAROTENE_UP | 4.74e-12 | 48 | 90 | 8 | MM531 | |
| Coexpression | OHGUCHI_LIVER_HNF4A_TARGETS_DN | SHLD2 PSG1 PSG3 PSG4 CYP4A11 PSG6 PSG9 CEACAM6 PSG8 SOAT2 CEACAM1 | 1.01e-10 | 201 | 90 | 11 | MM1294 |
| Coexpression | DESCARTES_FETAL_PLACENTA_TROPHOBLAST_GIANT_CELLS | 1.13e-09 | 93 | 90 | 8 | M40279 | |
| Coexpression | ZHANG_BREAST_CANCER_PROGENITORS_DN | 4.11e-09 | 159 | 90 | 9 | MM760 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP | 1.44e-08 | 128 | 90 | 8 | MM1000 | |
| Coexpression | HOLLERN_EMT_BREAST_TUMOR_DN | 2.18e-08 | 135 | 90 | 8 | MM965 | |
| Coexpression | BROWN_MYELOID_CELL_DEVELOPMENT_UP | 3.17e-08 | 201 | 90 | 9 | MM1006 | |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_5_6WK_UP | 3.43e-08 | 143 | 90 | 8 | MM989 | |
| Coexpression | SWEET_LUNG_CANCER_KRAS_UP | MRC1 PSG1 PSG3 PSG4 PSG6 PSG9 HPN LRP2 CEACAM6 ATP11A PSG8 CTSB CEACAM1 | 3.54e-08 | 534 | 90 | 13 | MM1050 |
| Coexpression | KUMAR_TARGETS_OF_MLL_AF9_FUSION | MRC1 PSG1 PSG3 PSG4 PSG6 PSG9 RUSC1 CEACAM6 PSG8 CTSB RYR1 CEACAM1 | 6.31e-08 | 463 | 90 | 12 | MM1011 |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_3_4WK_UP | 1.01e-07 | 230 | 90 | 9 | MM986 | |
| Coexpression | MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP | 2.21e-07 | 182 | 90 | 8 | MM993 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_DN | HDHD3 ZDHHC12 PSG1 PSG3 PSG4 PSG6 PSG9 HPN CEACAM6 PSG8 CEACAM1 | 3.04e-07 | 436 | 90 | 11 | MM1326 |
| Coexpression | TABULA_MURIS_SENIS_SUBCUTANEOUS_ADIPOSE_TISSUE_MYELOID_CELL_AGEING | 9.00e-07 | 219 | 90 | 8 | MM3826 | |
| Coexpression | DESCARTES_FETAL_ADRENAL_CSH1_CSH2_POSITIVE_CELLS | 1.07e-06 | 224 | 90 | 8 | M40145 | |
| Coexpression | KOBAYASHI_EGFR_SIGNALING_24HR_UP | 1.43e-06 | 102 | 90 | 6 | M10290 | |
| Coexpression | MARTINEZ_RB1_TARGETS_UP | PSG1 PSG3 PSG4 PSG6 MRC2 PSG9 TSPO CEACAM6 PSG8 PDPK2P CTSB RYR1 CEACAM1 | 1.47e-06 | 741 | 90 | 13 | MM1037 |
| Coexpression | DELYS_THYROID_CANCER_UP | 3.07e-06 | 445 | 90 | 10 | M3645 | |
| Coexpression | MARTINEZ_RB1_AND_TP53_TARGETS_UP | PSG1 PSG3 PSG4 PSG6 MRC2 PSG9 TSPO CEACAM6 PSG8 PDPK2P CTSB CEACAM1 | 4.17e-06 | 689 | 90 | 12 | MM1041 |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_4_5WK_UP | 6.19e-06 | 284 | 90 | 8 | MM987 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP | 7.15e-06 | 490 | 90 | 10 | MM1001 | |
| Coexpression | BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS | NOG PSG1 PSG3 PSG4 PSG6 PSG9 SLC27A1 CEACAM8 CEACAM6 PSG8 PGAP6 ALK CEACAM1 | 8.53e-06 | 871 | 90 | 13 | MM1005 |
| Coexpression | ZHANG_UTERUS_C1_REGENERATIVE_UP | 9.68e-06 | 302 | 90 | 8 | MM16604 | |
| Coexpression | TABULA_MURIS_SENIS_SUBCUTANEOUS_ADIPOSE_TISSUE_EPITHELIAL_CELL_AGEING | 2.55e-05 | 568 | 90 | 10 | MM3824 | |
| Coexpression | OUYANG_PROSTATE_CANCER_MARKERS | 4.98e-05 | 21 | 90 | 3 | M9874 | |
| Coexpression | PRC2_SUZ12_UP.V1_DN | 5.34e-05 | 192 | 90 | 6 | M2740 | |
| Coexpression | GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_18H_DN | 5.34e-05 | 192 | 90 | 6 | M4296 | |
| Coexpression | MEBARKI_HCC_PROGENITOR_WNT_DN_CTNNB1_DEPENDENT_BLOCKED_BY_FZD8CRD | 5.75e-05 | 22 | 90 | 3 | M38991 | |
| Coexpression | TRAVAGLINI_LUNG_ALVEOLAR_EPITHELIAL_TYPE_1_CELL | 6.10e-05 | 391 | 90 | 8 | M41659 | |
| Coexpression | MISSIAGLIA_REGULATED_BY_METHYLATION_UP | 7.23e-05 | 125 | 90 | 5 | M12272 | |
| Coexpression | GOZGIT_ESR1_TARGETS_DN | PSG3 PSG4 PSG6 PSG9 PPM1E CEACAM6 FUT8 MPPED2 PGAP6 STAT1 CEACAM1 | 7.93e-05 | 786 | 90 | 11 | M10961 |
| Coexpression | TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN | 9.36e-05 | 132 | 90 | 5 | M15410 | |
| Coexpression | MARTINEZ_TP53_TARGETS_UP | 1.35e-04 | 694 | 90 | 10 | MM1039 | |
| Coexpression | MEBARKI_HCC_PROGENITOR_WNT_DN_CTNNB1_DEPENDENT | 1.64e-04 | 31 | 90 | 3 | M38985 | |
| Coexpression | MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3 | 2.06e-04 | 350 | 90 | 7 | M1949 | |
| Coexpression | MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3 | 2.33e-04 | 357 | 90 | 7 | MM828 | |
| Coexpression | MEBARKI_HCC_PROGENITOR_WNT_DN | 2.88e-04 | 92 | 90 | 4 | M38983 | |
| Coexpression | DESCARTES_MAIN_FETAL_TROPHOBLAST_GIANT_CELLS | 3.13e-04 | 171 | 90 | 5 | M40134 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_INTERM_NEUROENDOCRINE_CELL | 3.28e-04 | 268 | 90 | 6 | M45696 | |
| Coexpression | GSE43863_NAIVE_VS_MEMORY_TH1_CD4_TCELL_D150_LCMV_DN | 4.49e-04 | 185 | 90 | 5 | M9718 | |
| CoexpressionAtlas | placenta | 2.09e-07 | 349 | 88 | 11 | placenta | |
| ToppCell | Biopsy_IPF-Epithelial-AT1|Biopsy_IPF / Sample group, Lineage and Cell type | 6.95e-09 | 198 | 90 | 8 | 75bdecbe111fededf6082b11de18b84ca308ef6d | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Keratinizing_Cervical_Squamous_Cell_Carcinoma-6|TCGA-Cervix / Sample_Type by Project: Shred V9 | 3.45e-07 | 136 | 90 | 6 | 2c723777fadc5946df67d3e992471d8134b827f4 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-Alveolar_Mac|metastatic_Lymph_Node / Location, Cell class and cell subclass | 7.44e-07 | 155 | 90 | 6 | 03fd443740272dcb547e39deaf7ae89b8307f241 | |
| ToppCell | TCGA-Adrenal-Primary_Tumor-Adrenocortical_carcinoma-Oncocytic_Type|TCGA-Adrenal / Sample_Type by Project: Shred V9 | 1.95e-06 | 101 | 90 | 5 | 715d1c0192b9f397f285fe695950ca030af3233f | |
| ToppCell | TCGA-Adrenal-Primary_Tumor-Adrenocortical_carcinoma-Oncocytic_Type-6|TCGA-Adrenal / Sample_Type by Project: Shred V9 | 1.95e-06 | 101 | 90 | 5 | b9df110a4dbd44d5e36a21ff976ffe5ef4e1c1c5 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D231|Adult / Lineage, Cell type, age group and donor | 2.36e-06 | 189 | 90 | 6 | 5a04cb25f8f0447b2cecdb6c3695029281aca26d | |
| ToppCell | AT1|World / shred by cell class for parenchyma | 2.91e-06 | 196 | 90 | 6 | 2bc487f8a109a6961ebff111dec79c2227ea60ac | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.35e-05 | 150 | 90 | 5 | 0205318a870e091add66ee4305747dda9f51510d | |
| ToppCell | 368C-Myeloid-Monocyte-CD16+_Monocyte|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.63e-05 | 156 | 90 | 5 | 25b0936960be4955b6a6d6b8a867fdd4be548f05 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.73e-05 | 158 | 90 | 5 | e7db0ee4740e3c7a4d97d7cd7462e2c2ab458a4b | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.73e-05 | 158 | 90 | 5 | d39e020c3e77eb9d3de600a171d22f94357061d4 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 1.79e-05 | 159 | 90 | 5 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|kidney / Disease (COVID-19 only), tissue and cell type | 2.01e-05 | 163 | 90 | 5 | 19c28ce16a588a7f4a035c32726f6ccd67702b5b | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l2-17-52|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.13e-05 | 165 | 90 | 5 | 354978d4f35154d7b2e36e94de669e045adef512 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-05 | 166 | 90 | 5 | 13027ae342994db4540e64eb910df1f42b160931 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-05 | 166 | 90 | 5 | b21e45bd43f26149b9cd6e45c19241c82d54fb2f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.26e-05 | 167 | 90 | 5 | 3edb0570e583bb527165bcd8a4c25a042054043b | |
| ToppCell | AT1-AT2_cells-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 2.83e-05 | 175 | 90 | 5 | bdd85ba280648a0283c1984662a34c7b840f64dd | |
| ToppCell | AT1_cells-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 2.91e-05 | 176 | 90 | 5 | 458720776b0151cd55acc352d509599cb62f0ca8 | |
| ToppCell | AT1_cells-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 2.91e-05 | 176 | 90 | 5 | 4a30bb771297b30926fb98e2b5ec0dbdc46feac7 | |
| ToppCell | COVID-19-Epithelial_cells-AT1|COVID-19 / group, cell type (main and fine annotations) | 3.15e-05 | 179 | 90 | 5 | a0b33bd69ffdfd5d38d80207fb40058a490aa19e | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Type_1_alveolar|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.15e-05 | 179 | 90 | 5 | d5763912a4ce7188535675e338799b856edb9dda | |
| ToppCell | AT1_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 3.15e-05 | 179 | 90 | 5 | 1603117b52623663458a977c94bf7f9f6c1114b8 | |
| ToppCell | Control-Myeloid-Alveolar_macrophages|Control / group, cell type (main and fine annotations) | 3.32e-05 | 181 | 90 | 5 | 8d2102c8c86c59a82610f26f90946b290552e666 | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_neutrophil-granulo-neutrophil-myelocyte|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.41e-05 | 182 | 90 | 5 | 52eac2f892ea7f26731e0b21c578fd2665a1657a | |
| ToppCell | COPD-Epithelial-ATI|World / Disease state, Lineage and Cell class | 3.41e-05 | 182 | 90 | 5 | e95d946a43b1579af199900bb0e3eacbb9d65300 | |
| ToppCell | facs-Trachea-24m-Epithelial-glandular_epithelial|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.59e-05 | 184 | 90 | 5 | 61caaa31975e05c9a6512079c791fed5a9e2d39f | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.59e-05 | 184 | 90 | 5 | 97ae5ffecf90df42cc8eea2a247ca589f35a4783 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.59e-05 | 184 | 90 | 5 | 57c792e6e2fedba25d3350ffe649fd74750b579d | |
| ToppCell | facs-Trachea-24m-Epithelial-glandular_epithelial-lung_secretory_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.59e-05 | 184 | 90 | 5 | 03da0f0f89f1ca5a3ccca1e22972f3129464e68e | |
| ToppCell | facs-Trachea-24m-Epithelial-glandular_epithelial-lung_secretory_cell-mucous|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.59e-05 | 184 | 90 | 5 | 9ed2a65a4ca0ebbbb89ace61027522f93369843d | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.59e-05 | 184 | 90 | 5 | d7bd0f0c607bade67c99e9fb3578a570298bf926 | |
| ToppCell | mild-Myeloid-Immature_Neutrophils_1|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.69e-05 | 185 | 90 | 5 | d747bc91fc276f12a5572ab0223fc71f829a5110 | |
| ToppCell | metastatic_Brain-Myeloid_cells-Alveolar_Mac|metastatic_Brain / Location, Cell class and cell subclass | 3.78e-05 | 186 | 90 | 5 | 9270e04c61b743874424a5935537b62e7d89c461 | |
| ToppCell | wk_20-22-Hematologic-Myeloid-Myelocyte-like|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.78e-05 | 186 | 90 | 5 | 53b4ce33ae6fa32f1b56cbc62b1d7915e935afc9 | |
| ToppCell | COPD-Epithelial-ATI|COPD / Disease state, Lineage and Cell class | 3.78e-05 | 186 | 90 | 5 | df0977f6f48a2d4e11b59971f098b01204242f0f | |
| ToppCell | AT1_cells-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 3.88e-05 | 187 | 90 | 5 | f1dda349335e08dbfc8395d373924037f5ad2fd6 | |
| ToppCell | COVID-19-kidney-Mito-rich_PCT|kidney / Disease (COVID-19 only), tissue and cell type | 3.88e-05 | 187 | 90 | 5 | 738ec2611b4be6a08eedad16b57fba84e1f11fef | |
| ToppCell | metastatic_Brain-Myeloid_cells-Alveolar_Mac|Myeloid_cells / Location, Cell class and cell subclass | 3.88e-05 | 187 | 90 | 5 | 7375f70a970a5d5a58b7c33ada2dcf6dcef525c6 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-I_(AT1)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.98e-05 | 188 | 90 | 5 | c74771584b3ba9561a99a54bf55a9203ddf8eff8 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.98e-05 | 188 | 90 | 5 | 43a0508d2524a5b310e89e9422843dcaab999bc3 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-I_(AT1)|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.98e-05 | 188 | 90 | 5 | 9155b9a92496e75646778c025b02947e9e9ec73a | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil-Neu_2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.08e-05 | 189 | 90 | 5 | 3b35022c0619df6db234613aa53a076899ca9562 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil-Neu_2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.08e-05 | 189 | 90 | 5 | 358ff514f1c8aa46067208ddf1b68396d789c130 | |
| ToppCell | mild-Myeloid-Immature_Neutrophils_1|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 4.08e-05 | 189 | 90 | 5 | 94dd5d4d815449feff7ce157fe7f8234f7c81422 | |
| ToppCell | wk_08-11-Epithelial-Proximal_epithelial-intermediate_neuroendocrine|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 4.19e-05 | 190 | 90 | 5 | 5f1863bce9400b7c932f0e4d0e012ec4e8d7e555 | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-myeloid-myeloid_monocytic-intermediate_monocyte|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.19e-05 | 190 | 90 | 5 | 896b5825edb30fe62cbbed6078570c1f8057a99e | |
| ToppCell | control-Myeloid-Immature_Neutrophils_1|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 4.19e-05 | 190 | 90 | 5 | 38e83337c70c8734b63f8589ba59e0f98603f94c | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.29e-05 | 191 | 90 | 5 | 6c1283d51a845cff67ed5e500f7e944165297b53 | |
| ToppCell | LAM-Epithelial-AT1|Epithelial / Condition, Lineage and Cell class | 4.29e-05 | 191 | 90 | 5 | 3457e15d1e9b36a78363d46b320c4ec46b40290a | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW19|fetalBrain_Zhong_nature / Sample Type, Dataset, Time_group, and Cell type. | 4.29e-05 | 191 | 90 | 5 | b5328733da3d3d77c4f6fc5e2ba2035f8898f172 | |
| ToppCell | LAM-Epithelial-AT1|LAM / Condition, Lineage and Cell class | 4.29e-05 | 191 | 90 | 5 | 66875b2ec2c510489407f3e433a90cdf74a15094 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.40e-05 | 192 | 90 | 5 | 86d561c30554ff04c21801d4aaf8e3c9efe49af4 | |
| ToppCell | COVID-19_Severe-Myeloid_G-immature_Neutrophil|COVID-19_Severe / Disease group, lineage and cell class | 4.40e-05 | 192 | 90 | 5 | 303deb68da2e4a75e6ee5a79478182a8bc41c7c5 | |
| ToppCell | control-Myeloid-Immature_Neutrophils_1|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 4.40e-05 | 192 | 90 | 5 | 9f12b79d661ef0f57c2c924e8ecc24a46ea996d2 | |
| ToppCell | AT1_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 4.40e-05 | 192 | 90 | 5 | 0444f9e9cef7403e220e862b5a787443d3f5c9ac | |
| ToppCell | (3)_Macrophage_MARCOpos|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 4.40e-05 | 192 | 90 | 5 | b1e2175bd4c02106e52d8f491eea1329ac327ae9 | |
| ToppCell | Macrophages-Donor_05|World / lung cells shred on cell class, cell subclass, sample id | 4.51e-05 | 193 | 90 | 5 | 7254b730fc4e8b6837601141e37aa39ac680ecbb | |
| ToppCell | 343B-Myeloid-Macrophage-FABP4+_Macrophage_4|343B / Donor, Lineage, Cell class and subclass (all cells) | 4.51e-05 | 193 | 90 | 5 | b9dcffd28ca309359fb110fb79de8ce066208ee1 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-I_(AT1)|356C / Donor, Lineage, Cell class and subclass (all cells) | 4.74e-05 | 195 | 90 | 5 | 07a3ef6b0f1201fe2bcb9ea426b8f7a69beb4904 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-AT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.74e-05 | 195 | 90 | 5 | a71ba5e4043e2d35a45a2c60a96b087e31832345 | |
| ToppCell | COVID_vent-Myeloid-Monocytic-Developing_Neutrophil|COVID_vent / Disease condition, Lineage, Cell class and subclass | 4.74e-05 | 195 | 90 | 5 | de23409b1b4146b8ae286850b829ec8dceed0117 | |
| ToppCell | AT1_cells|World / lung cells shred on cell class, cell subclass, sample id | 4.74e-05 | 195 | 90 | 5 | 792d6a49b0a875a00569071183d195287a9925c5 | |
| ToppCell | LAM-Myeloid-Macrophage|LAM / Condition, Lineage and Cell class | 4.74e-05 | 195 | 90 | 5 | 85abe51e47b567e6edcadfbe8cf02c2f2f0bb133 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-I_(AT1)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 4.74e-05 | 195 | 90 | 5 | b65511770ed67f7447847e2187555b362988af45 | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_neutrophil-granulo-neutrophil|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.74e-05 | 195 | 90 | 5 | fb3dc2c8fd125f23d0c3aa211520778aac8d6dda | |
| ToppCell | severe-Myeloid-Immature_Neutrophils_1|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 4.74e-05 | 195 | 90 | 5 | becad890a420267ca41e98e61a8da343b51e1945 | |
| ToppCell | wk_20-22-Epithelial-Distal_epithelial-type_I_pneumocyte|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 4.85e-05 | 196 | 90 | 5 | e24a7aaf41793abba66c1189d933ca05b14c1af9 | |
| ToppCell | Epithelial_cells-AT1_cells|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 4.85e-05 | 196 | 90 | 5 | 6c99d29162848161c1f166a032320f87a5d5a631 | |
| ToppCell | (7)_Epithelial-I_(AT1)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 4.85e-05 | 196 | 90 | 5 | 150554fa06868d29b0608189862eef6505ba757f | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.97e-05 | 197 | 90 | 5 | c9c968e223e7814cd8d22975d849a31b7e0af7aa | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.97e-05 | 197 | 90 | 5 | 8d5097898dd01cedb04cb694cb480c931e08462c | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.97e-05 | 197 | 90 | 5 | 734b8db5bb4917c9ce92ed342fe6c22b64b0d3c5 | |
| ToppCell | severe-Myeloid-Immature_Neutrophils_1|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 4.97e-05 | 197 | 90 | 5 | 9599319dd1f80c81356a8624131566cc76d77d7e | |
| ToppCell | ASK440-Epithelial-Type_1|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 4.97e-05 | 197 | 90 | 5 | 1eda2c2504451a3d626dda5c2b2b12eeaa6bca54 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.97e-05 | 197 | 90 | 5 | e344455e62b3fe94bb242dc0db58d19a1d3878c7 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.97e-05 | 197 | 90 | 5 | 2e622d75fb45cfa80f78e1880ad056a50709895a | |
| ToppCell | 10x3'2.3-week_17-19-Myeloid_neutrophil-granulo-neutrophil|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.09e-05 | 198 | 90 | 5 | 82f6ac18c3a6487f03579b5c247844f1c115c2be | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_alveolar-AT1|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.09e-05 | 198 | 90 | 5 | 54228dd9a50616d2022712d162a419ed0327cabd | |
| ToppCell | 10x3'2.3-week_17-19-Myeloid_neutrophil-granulo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.09e-05 | 198 | 90 | 5 | f870e398e996c1f28c8462d87b18f71b20c71011 | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Macrophage_other-Macrophage_intravascular|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.09e-05 | 198 | 90 | 5 | c7dbf24caae5c4ef285845d13055de9e07281bb3 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-2_Progenitor-Progenitor_AT1-AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.09e-05 | 198 | 90 | 5 | 8d9858dcb21f20d0c040b22a2cae543eaebd54bc | |
| ToppCell | 10x3'2.3-week_12-13-Myeloid_neutrophil-granulo-neutrophil-myelocyte|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.09e-05 | 198 | 90 | 5 | c65103828a4755fcf3c0776c60d8ada1f0ad5278 | |
| ToppCell | 10x3'2.3-week_17-19-Myeloid_neutrophil-granulo-neutrophil-myelocyte|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.09e-05 | 198 | 90 | 5 | 3bc05b8d97a7219af40db7a11aa271f02e74fca5 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.09e-05 | 198 | 90 | 5 | 1774dd36315a04c4cdcef2cc674204e4ab9c175b | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.09e-05 | 198 | 90 | 5 | 768df928a3265dbe7cce2acea07b2f6d6b709642 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_alveolar-AT1|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.22e-05 | 199 | 90 | 5 | aca81a879ef9c196bd1885eff4c63ffe6c9682b7 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_neutrophil-granulo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.22e-05 | 199 | 90 | 5 | 5919933c4b842b98fc98685dc8c72c8dd32c6ea3 | |
| ToppCell | cellseq-Immune-Immune_Myeloid-AM-AM|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.22e-05 | 199 | 90 | 5 | 255cf629351f35e516a5271d8758c29168ebd0cf | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.22e-05 | 199 | 90 | 5 | e29cd315662a8a33470964d102a61f5d3f6797e9 | |
| ToppCell | Bronchial-10x5prime-Immune_Myeloid-Macrophage_alveolar-Macro_alv_MT|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.22e-05 | 199 | 90 | 5 | a1ff1063741f6e5569feb44245785c9f472799b2 | |
| ToppCell | (7)_Epithelial_cells-(7)_Epithelial-I_(AT1)|(7)_Epithelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 5.22e-05 | 199 | 90 | 5 | 5a002d49a8b84c158f7b4d7a3e78e6a937757bb7 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.22e-05 | 199 | 90 | 5 | 5363c6df26f595f218933e38c9f628b22c6f9edd | |
| ToppCell | cellseq-Immune-Immune_Myeloid-AM|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.22e-05 | 199 | 90 | 5 | 298302123a2b3815ed98130fa1a229e56e8ab77b | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-AT1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.22e-05 | 199 | 90 | 5 | 8c9ec5f05b79cf5ae1bf7aade603c171fb0226a9 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_neutrophil-granulo-neutrophil-myelocyte|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.22e-05 | 199 | 90 | 5 | a1635a52318be0423f8e4fc03d971c28cd22b57e | |
| ToppCell | 3'_v3-Lung-Myeloid_Mac|Lung / Manually curated celltypes from each tissue | 5.22e-05 | 199 | 90 | 5 | 1677aaee5b7f5f262e27df5d9f1bdf6e21e3d804 | |
| ToppCell | Biopsy_IPF-Epithelial-Transitional_AT2|Biopsy_IPF / Sample group, Lineage and Cell type | 5.22e-05 | 199 | 90 | 5 | 83ff8b7e472d1212324c05cc719b746d19e5e23b | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.22e-05 | 199 | 90 | 5 | 87956fcb39c2e3e99622ff05f99267d7621a78fc | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.22e-05 | 199 | 90 | 5 | a270630626df614f8605abddb7dee7c4d74f6149 | |
| Computational | Neighborhood of EGFR | 1.24e-08 | 32 | 56 | 6 | GNF2_EGFR | |
| Computational | Neighborhood of IGFBP1 | 2.19e-08 | 35 | 56 | 6 | GNF2_IGFBP1 | |
| Computational | Neighborhood of MMP11 | 6.89e-08 | 42 | 56 | 6 | GNF2_MMP11 | |
| Computational | Neighborhood of TIMP2 | 1.21e-07 | 46 | 56 | 6 | GNF2_TIMP2 | |
| Computational | Neighborhood of KISS1 | 1.79e-07 | 49 | 56 | 6 | GNF2_KISS1 | |
| Computational | Neighborhood of CDKN1C | 2.37e-07 | 27 | 56 | 5 | GNF2_CDKN1C | |
| Computational | Neighborhood of IL4 | 4.64e-04 | 192 | 56 | 6 | MORF_IL4 | |
| Computational | Neighborhood of CAMK4 | 7.23e-04 | 290 | 56 | 7 | MORF_CAMK4 | |
| Computational | Neighborhood of RAD51L3 | 8.20e-04 | 387 | 56 | 8 | MORF_RAD51L3 | |
| Computational | Neighborhood of MAGEA9 | 1.46e-03 | 423 | 56 | 8 | MORF_MAGEA9 | |
| Computational | Neighborhood of SUPT3H | 1.48e-03 | 328 | 56 | 7 | MORF_SUPT3H | |
| Computational | Neighborhood of ATF2 | 1.54e-03 | 330 | 56 | 7 | MORF_ATF2 | |
| Drug | AC1L1IPV | 7.58e-16 | 43 | 88 | 10 | CID000004683 | |
| Drug | AC1L2AC7 | 2.77e-07 | 69 | 88 | 6 | CID000068733 | |
| Drug | Rgd Peptide | 3.70e-07 | 239 | 88 | 9 | CID000104802 | |
| Drug | propanoyl | 4.61e-06 | 9 | 88 | 3 | CID000139982 | |
| Drug | pP-8 | 6.57e-06 | 10 | 88 | 3 | CID000444681 | |
| Drug | H S Q | 8.70e-06 | 351 | 88 | 9 | CID000000897 | |
| Drug | leys | 9.00e-06 | 11 | 88 | 3 | CID000484683 | |
| Drug | C-E6 | 1.20e-05 | 12 | 88 | 3 | CID000444208 | |
| Drug | Levetiracetam | 1.48e-05 | 2 | 88 | 2 | DB01202 | |
| Drug | 9,10-methylenehexadecanoic acid | 1.48e-05 | 2 | 88 | 2 | CID000160786 | |
| Drug | AC1L1JG6 | 1.97e-05 | 14 | 88 | 3 | CID000005026 | |
| Drug | 3-chloropropanoyl chloride | 4.42e-05 | 3 | 88 | 2 | CID000069364 | |
| Disease | cD177 antigen measurement | 9.26e-12 | 18 | 86 | 6 | EFO_0021866 | |
| Disease | Congenital disorder of glycosylation with defective fucosylation | 8.40e-06 | 2 | 86 | 2 | cv:C4693905 | |
| Disease | familial hemiplegic migraine 1 (implicated_via_orthology) | 2.51e-05 | 3 | 86 | 2 | DOID:0111181 (implicated_via_orthology) | |
| Disease | pregnancy-specific beta-1-glycoprotein 9 measurement | 5.02e-05 | 4 | 86 | 2 | EFO_0801909 | |
| Disease | migraine (implicated_via_orthology) | 5.02e-05 | 4 | 86 | 2 | DOID:6364 (implicated_via_orthology) | |
| Disease | trichloroethylene-induced hypersensitivity | 5.02e-05 | 4 | 86 | 2 | EFO_0007685 | |
| Disease | pregnancy-specific beta-1-glycoprotein 4 measurement | 1.25e-04 | 6 | 86 | 2 | EFO_0801907 | |
| Disease | glucose intolerance (biomarker_via_orthology) | 1.25e-04 | 6 | 86 | 2 | DOID:10603 (biomarker_via_orthology) | |
| Disease | hereditary ataxia (implicated_via_orthology) | 1.75e-04 | 7 | 86 | 2 | DOID:0050951 (implicated_via_orthology) | |
| Disease | trefoil factor 3 measurement | 1.75e-04 | 7 | 86 | 2 | EFO_0008304 | |
| Disease | 11beta-hydroxyandrosterone glucuronide measurement | 5.44e-04 | 12 | 86 | 2 | EFO_0800573 | |
| Disease | Generalized hypotonia | 8.60e-04 | 15 | 86 | 2 | C1858120 | |
| Disease | iritis | 1.11e-03 | 17 | 86 | 2 | EFO_1000997 | |
| Disease | Feeding difficulties | 1.25e-03 | 18 | 86 | 2 | C0232466 | |
| Disease | polycystic kidney disease (biomarker_via_orthology) | 1.39e-03 | 19 | 86 | 2 | DOID:0080322 (biomarker_via_orthology) | |
| Disease | androsterone glucuronide measurement | 1.54e-03 | 20 | 86 | 2 | EFO_0800317 | |
| Disease | nighttime rest measurement | 2.22e-03 | 24 | 86 | 2 | EFO_0007827 | |
| Disease | nephrotic syndrome (implicated_via_orthology) | 2.22e-03 | 24 | 86 | 2 | DOID:1184 (implicated_via_orthology) | |
| Disease | alpha-2-macroglobulin receptor-associated protein measurement | 2.22e-03 | 24 | 86 | 2 | EFO_0008021 | |
| Disease | acute necrotizing pancreatitis (biomarker_via_orthology) | 2.61e-03 | 26 | 86 | 2 | DOID:0080998 (biomarker_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SGNTWNWLYFIPLII | 331 | O00555 | |
| ARLSPAAGYWVLGLW | 411 | Q6UXG8 | |
| RILGWGVENGTPYWL | 281 | P07858 | |
| GVENGTPYWLVANSW | 286 | P07858 | |
| YNGWIWGHQGPQLLT | 241 | Q9NPC4 | |
| LDYWGPNSGPLTWRL | 746 | Q9H9E3 | |
| YLWWVNGQSLPVSPR | 176 | P31997 | |
| LQLPTVWRENSGSYW | 246 | Q96PJ5 | |
| WIGYGLLLLNGQTWF | 126 | Q02928 | |
| WQYGPCTGITRLQRW | 56 | Q9HCU8 | |
| GDILPNANWTWYLRA | 251 | P29016 | |
| CWRLPGVYWQNGLSP | 61 | Q3ZCQ2 | |
| AAGNTWNWLYFIPLI | 326 | Q00975 | |
| IYIWGWNESGQLALP | 231 | A6NED2 | |
| PNYGLSHGLTSRQWW | 61 | Q9BSH5 | |
| NQVDWNAWLYSPGLP | 441 | P09960 | |
| YPWNITLSWRQDGVS | 231 | Q29983 | |
| WGFNLPRGQSLLDKW | 186 | Q15777 | |
| ISYWPQLALGLTFNW | 201 | Q96H96 | |
| WWQSPPLSSGTQYNR | 126 | Q16787 | |
| AGLPWWFLGNLRSNY | 196 | O15151 | |
| LPGLWNQSRRGYWSC | 71 | Q8TDU6 | |
| WVGNDWLPSLGLPQY | 956 | O75145 | |
| YLWWVNGQSLPVSPR | 176 | P40199 | |
| WIGNEWLPSLGLPQY | 966 | Q13136 | |
| SGGWQWSDNSPLKYL | 306 | Q9UBG0 | |
| WPNGLAIDWAASRLY | 871 | P98164 | |
| TSWQRWAFYLLPGVS | 686 | Q9HCN3 | |
| YGNVSWPGWRARQVA | 346 | Q6A1A2 | |
| YLSGWQPRWFLLCGG | 11 | Q96JA3 | |
| RWWQSPPLSRGLEYN | 126 | O15230 | |
| LGRWPWQVSLRYDGA | 171 | P05981 | |
| IRSSLPWRQNSWKGY | 716 | Q8WY54 | |
| LAWAGAPLLGWNRYI | 166 | Q9H1Y3 | |
| WERQGAGTYLNVPWS | 446 | Q8N0W3 | |
| LWGPQGTLLTWTYRG | 106 | Q8N8I6 | |
| YVTGWGRLWTNGPIA | 156 | Q99895 | |
| TWEQGRYLIWNPCSG | 1401 | Q9P2K1 | |
| PSVLRSWNWGLCGYF | 211 | Q9HCG7 | |
| YLWWINNQSLPVSPR | 176 | P13688 | |
| QYQAPSTRWGSALWK | 126 | A6NCJ1 | |
| QALWIFGYGSLVWRP | 31 | Q9BUX1 | |
| LWNSSAALYPSIGVW | 251 | Q2M3T9 | |
| NPWYTWLKNGERLNP | 346 | Q9UQ52 | |
| QRDLPGWSRYWISGN | 66 | Q6UWL6 | |
| QLGWLWGQSRALYPS | 231 | Q12794 | |
| NGWNRDAYSLRIWGL | 651 | Q8IXB1 | |
| AYWNQQQWRLGSLPS | 71 | Q7Z7M8 | |
| YIWWLNGQSLPVSPR | 271 | Q00888 | |
| PGLAYAIPQWRWLQL | 226 | Q8TCC7 | |
| WALTRIEQGWTYGPV | 881 | P21817 | |
| PESWLNSLGLTYWPQ | 61 | P57054 | |
| YIWWLNGQSLPVSPR | 271 | P11464 | |
| YIWWLNGQSLPVSPR | 271 | Q16557 | |
| PVLYAWNDLGSRFWP | 156 | Q13253 | |
| GLWIGLNSLSFNSGW | 276 | P22897 | |
| QWSDRSPFRYLNWLP | 291 | P22897 | |
| LILESQNWRYATGGW | 241 | Q9BYC5 | |
| PGSWWEQLTQASRVY | 726 | Q9BVN2 | |
| WYARNPPGWSQLFLG | 31 | Q96GJ1 | |
| LLWGGVPQYSSSLWG | 1646 | Q9HCJ0 | |
| VSQLPSGWASILWYN | 461 | P42224 | |
| RAVSGWGVPQLLWYL | 21 | Q17RQ9 | |
| RNYTYIWWLNGQSLP | 266 | Q00889 | |
| YIWWLNGQSLPVSPR | 271 | Q9UQ74 | |
| YIWWLNGQSLPVSPG | 271 | Q00887 | |
| DAAAGQWPWQASLLY | 86 | A8MTI9 | |
| ALVLWGPGAAWYPQL | 636 | Q86V20 | |
| YIWWLNGQSLPVSPR | 271 | Q13046 | |
| YQWPWTLLLLAVSGF | 256 | Q96K37 | |
| AGWQWSDGTPLNYLN | 301 | Q13018 | |
| WPISGGAWNLGAQTY | 446 | Q9Y2K9 | |
| WYQRWGVRALSLGGQ | 416 | Q7L0J3 | |
| PYQALRLWARGTWTQ | 181 | O75908 | |
| RNKPTSLWNPTYGSW | 1496 | Q9UM73 | |
| SLLWGGVIWPFLNYQ | 1046 | P98196 | |
| LWWSPTINRANVYVG | 1536 | Q6P2Q9 | |
| WGASLPEAQVWGYLR | 201 | Q99640 | |
| GLPWTWSAAAALGVY | 21 | Q6PCB7 | |
| LSWLNASWFRGLGNL | 296 | Q9NR96 | |
| WGLLWLLLGSAGAQY | 6 | Q92791 | |
| GGNPWAAVLYSWGLV | 391 | Q9BXP2 | |
| DLGQTYNPWRIWSPT | 1851 | Q92545 | |
| SLQGYSWLGETLPLW | 536 | Q6NUQ4 | |
| GTRVLAGYPIWWSLA | 16 | P56703 | |
| AGYPIWWSLALGQQY | 21 | P56703 | |
| WWSLALGQQYTSLGS | 26 | P56703 | |
| WIGYALATWSLPALA | 201 | P31213 | |
| SQQPGYSQWGWLLPG | 236 | O15178 | |
| YSQWGWLLPGTSTLC | 241 | O15178 | |
| YGWETRSGQLLWRLG | 46 | Q5JTN6 | |
| PIWWSLAVGPQYSSL | 21 | P56704 | |
| FFQPWGQWLRSSGLL | 166 | Q96GR4 | |
| PLGLYTGQLALNWAW | 81 | P30536 | |
| ILWGLPLQYGWQYRT | 86 | Q6P5S2 | |
| IQWYRNGVPLSPSKW | 441 | P52179 | |
| PIWSTWALYGRAVDQ | 316 | Q6NSJ0 |